823 results on '"JELAKOVIĆ, BOJAN"'
Search Results
102. Berlin Initiative Study 1 equation and HUGE formula for more accurate estimation of kidney function in elderly
- Author
-
Matašin, Marija, primary, Domislović, Viktor, additional, Fuček, Mirjana, additional, Gellineo, Lana, additional, Jelaković, Ana, additional, Dika, Živka, additional, and Jelaković, Bojan, additional
- Published
- 2021
- Full Text
- View/download PDF
103. TP53 Mutational signature for aristolochic acid: an environmental carcinogen
- Author
-
Moriya, Masaaki, Slade, Neda, Brdar, Branko, Medverec, Zvonimir, Tomic, Karla, Jelaković, Bojan, Wu, Lin, Truong, Sim, Fernandes, Andrea, and Grollman, Arthur P.
- Published
- 2011
- Full Text
- View/download PDF
104. Corrigendum to “The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes”
- Author
-
Premužić, Vedran, primary, Padjen, Ivan, additional, Cerovec, Mislav, additional, Laganović, Mario, additional, Željković-Vrkić, Tajana, additional, Kos, Jelena, additional, Ćorić, Marijana, additional, Jelaković, Bojan, additional, and Anić, Branimir, additional
- Published
- 2020
- Full Text
- View/download PDF
105. Ambulatory blood pressure profile in office normotensive obese children: prevalence of masked hypertension and impact of parental hypertension
- Author
-
Valent Morić, Bernardica, primary, Jelaković, Bojan, additional, Vidatić, Ines, additional, Trutin, Ivana, additional, Jelaković, Ana, additional, and Stipančić, Gordana, additional
- Published
- 2020
- Full Text
- View/download PDF
106. The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes
- Author
-
Premužić, Vedran, primary, Padjen, Ivan, additional, Cerovec, Mislav, additional, Ćorić, Marijana, additional, Jelaković, Bojan, additional, and Anić, Branimir, additional
- Published
- 2020
- Full Text
- View/download PDF
107. Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants
- Author
-
Yiallouros, Panayiotis K., Escobedo-de la Peña, Jorge, Zhou, Bin, Bentham, James, Di Cesare, Mariachiara, Bixby, Honor, Danaei, Goodarz, Hajifathalian, Kaveh, Taddei, Cristina, Carrillo-Larco, Rodrigo M., Djalalinia, Shirin, Khatibzadeh, Shahab, Lugero, Charles, Peykari, Niloofar, Zhang, Wan Zhu, Bennett, James, Bilano, Ver, Stevens, Gretchen A., Cowan, Melanie J., Riley, Leanne M., Chen, Zhengming, Hambleton, Ian R., Jackson, Rod T., Kengne, Andre Pascal, Khang, Young-Ho, Laxmaiah, Avula, Liu, Jing, Malekzadeh, Reza, Neuhauser, Hannelore K., Sorić, Maroje, Starc, Gregor, Sundström, Johan, Woodward, Mark, Ezzati, Majid, Abarca-Gómez, Leandra, Abdeen, Ziad A., Abu-Rmeileh, Niveen M., Acosta-Cazares, Benjamin, Adams, Robert J., Aekplakorn, Wichai, Afsana, Kaosar, Aguilar-Salinas, Carlos A., Agyemang, Charles, Ahmad, Noor Ani, Ahmadvand, Alireza, Ahrens, Wolfgang, Ajlouni, Kamel, Akhtaeva, Nazgul, Al-Raddadi, Rajaa, Ali, Mohamed M., Ali, Osman, Alkerwi, Ala'a, Aly, Eman, Amarapurkar, Deepak N., Amouyel, Philippe, Amuzu, Antoinette, Andersen, Lars Bo, Anderssen, Sigmund A., Ängquist, Lars H., Anjana, Ranjit Mohan, Ansong, Daniel, Aounallah-Skhiri, Hajer, Araújo, Joana, Ariansen, Inger, Aris, Tahir, Arlappa, Nimmathota, Arveiler, Dominique, Aryal, Krishna K., Aspelund, Thor, Assah, Felix K., Assunção, Maria Cecília F., Avdicová, Mária, Azevedo, Ana, Azizi, Fereidoun, Babu, Bontha V., Bahijri, Suhad, Balakrishna, Nagalla, Bamoshmoosh, Mohamed, Banach, Maciej, Bandosz, Piotr, Banegas, José R., Barbagallo, Carlo M., Barceló, Alberto, Barkat, Amina, Barros, Aluisio J. D., Barros, Mauro V., Bata, Iqbal, Batieha, Anwar M., Batyrbek, Assembekov, Baur, Louise A., Beaglehole, Robert, Romdhane, Habiba Ben, Benet, Mikhail, Benson, Lowell S., Bernabe-Ortiz, Antonio, Bernotiene, Gailute, Bettiol, Heloisa, Bhagyalaxmi, Aroor, Bharadwaj, Sumit, Bhargava, Santosh K., Bi, Yufang, Bikbov, Mukharram, Bista, Bihungum, Bjerregaard, Peter, Bjertness, Espen, Bjertness, Marius B., Björkelund, Cecilia, Blokstra, Anneke, Bo, Simona, Bobak, Martin, Boeing, Heiner, Boggia, Jose G., Boissonnet, Carlos P., Bongard, Vanina, Borchini, Rossana, Bovet, Pascal, Braeckman, Lutgart, Brajkovich, Imperia, Branca, Francesco, Breckenkamp, Juergen, Brenner, Hermann, Brewster, Lizzy M., Bruno, Graziella, Bueno-de-Mesquita, H. B(as), Bugge, Anna, Burns, Con, Bursztyn, Michael, de León, Antonio Cabrera, Cacciottolo, Joseph, Cai, Hui, Cameron, Christine, Can, Günay, Cândido, Ana Paula C., Capuano, Vincenzo, Cardoso, Viviane C., Carlsson, Axel C., Carvalho, Maria J., Casanueva, Felipe F., Casas, Juan-Pablo, Caserta, Carmelo A., Chamukuttan, Snehalatha, Chan, Angelique W., Chan, Queenie, Chaturvedi, Himanshu K., Chaturvedi, Nishi, Chen, Chien-Jen, Chen, Fangfang, Chen, Huashuai, Chen, Shuohua, Cheng, Ching-Yu, Dekkaki, Imane Cherkaoui, Chetrit, Angela, Chiolero, Arnaud, Chiou, Shu-Ti, Chirita-Emandi, Adela, Chirlaque, María-Dolores, Cho, Belong, Cho, Yumi, Christofaro, Diego G., Chudek, Jerzy, Cifkova, Renata, Cinteza, Eliza, Claessens, Frank, Clays, Els, Concin, Hans, Cooper, Cyrus, Cooper, Rachel, Coppinger, Tara C., Costanzo, Simona, Cottel, Dominique, Cowell, Chris, Craig, Cora L., Crujeiras, Ana B., Cruz, Juan J., D'Arrigo, Graziella, d'Orsi, Eleonora, Dallongeville, Jean, Damasceno, Albertino, Dankner, Rachel, Dantoft, Thomas M., Dauchet, Luc, Davletov, Kairat, De Backer, Guy, De Bacquer, Dirk, de Gaetano, Giovanni, De Henauw, Stefaan, de Oliveira, Paula Duarte, De Smedt, Delphine, Deepa, Mohan, Dehghan, Abbas, Delisle, Hélène, Deschamps, Valérie, Dhana, Klodian, Di Castelnuovo, Augusto F., Dias-da-Costa, Juvenal Soares, Diaz, Alejandro, Dickerson, Ty T., Do, Ha T. P., Donfrancesco, Chiara, Donoso, Silvana P., Döring, Angela, Dorobantu, Maria, Doua, Kouamelan, Drygas, Wojciech, Dulskiene, Virginija, Džakula, Aleksandar, Dzerve, Vilnis, Dziankowska-Zaborszczyk, Elzbieta, Eggertsen, Robert, Ekelund, Ulf, El Ati, Jalila, Elliott, Paul, Elosua, Roberto, Erasmus, Rajiv T., Erem, Cihangir, Eriksen, Louise, Eriksson, Johan G., Evans, Alun, Faeh, David, Fall, Caroline H., Farzadfar, Farshad, Felix-Redondo, Francisco J., Ferguson, Trevor S., Fernandes, Romulo A., Fernández-Bergés, Daniel, Ferrante, Daniel, Ferrari, Marika, Ferreccio, Catterina, Ferrieres, Jean, Finn, Joseph D., Fischer, Krista, Föger, Bernhard, Foo, Leng Huat, Forslund, Ann-Sofie, Forsner, Maria, Fouad, Heba M., Francis, Damian K., do Carmo Franco, Maria, Franco, Oscar H., Frontera, Guillermo, Fuchs, Flavio D., Fuchs, Sandra C., Fujita, Yuki, Furusawa, Takuro, Gaciong, Zbigniew, Galvano, Fabio, Garcia-de-la-Hera, Manoli, Gareta, Dickman, Garnett, Sarah P., Gaspoz, Jean-Michel, Gasull, Magda, Gates, Louise, Geleijnse, Johanna M., Ghasemian, Anoosheh, Ghimire, Anup, Giampaoli, Simona, Gianfagna, Francesco, Gill, Tiffany K., Giovannelli, Jonathan, Goldsmith, Rebecca A., Gonçalves, Helen, Gonzalez-Gross, Marcela, González-Rivas, Juan P., Gorbea, Mariano Bonet, Gottrand, Frederic, Graff-Iversen, Sidsel, Grafnetter, Dušan, Grajda, Aneta, Grammatikopoulou, Maria G., Gregor, Ronald D., Grodzicki, Tomasz, Grøntved, Anders, Grosso, Giuseppe, Gruden, Gabriella, Grujic, Vera, Gu, Dongfeng, Guan, Ong Peng, Gudmundsson, Elias F., Gudnason, Vilmundur, Guerrero, Ramiro, Guessous, Idris, Guimaraes, Andre L., Gulliford, Martin C., Gunnlaugsdottir, Johanna, Gunter, Marc, Gupta, Prakash C., Gupta, Rajeev, Gureje, Oye, Gurzkowska, Beata, Gutierrez, Laura, Gutzwiller, Felix, Hadaegh, Farzad, Halkjær, Jytte, Hardy, Rebecca, Hari Kumar, Rachakulla, Hata, Jun, Hayes, Alison J., He, Jiang, He, Yuna, Elisabeth, Marleen, Henriques, Ana, Cadena, Leticia Hernandez, Herrala, Sauli, Heshmat, Ramin, Hihtaniemi, Ilpo Tapani, Ho, Sai Yin, Ho, Suzanne C., Hobbs, Michael, Hofman, Albert, Dinc, Gonul Horasan, Horimoto, Andrea R. V. R., Hormiga, Claudia M., Horta, Bernardo L., Houti, Leila, Howitt, Christina, Htay, Thein Thein, Htet, Aung Soe, Than Htike, Maung Maung, Hu, Yonghua, Huerta, José María, Huisman, Martijn, Husseini, Abdullatif S., Huybrechts, Inge, Hwalla, Nahla, Iacoviello, Licia, Iannone, Anna G., Ibrahim, Mohsen M., Wong, Norazizah Ibrahim, Ikeda, Nayu, Ikram, M. Arfan, Irazola, Vilma E., Islam, Muhammad, al-Safi Ismail, Aziz, Ivkovic, Vanja, Iwasaki, Masanori, Jacobs, Jeremy M., Jaddou, Hashem, Jafar, Tazeen, Jamrozik, Konrad, Janszky, Imre, Jasienska, Grazyna, Jelaković, Ana, Jelaković, Bojan, Jennings, Garry, Jeong, Seung-lyeal, Jiang, Chao Qiang, Joffres, Michel, Johansson, Mattias, Jokelainen, Jari J., Jonas, Jost B., Jørgensen, Torben, Joshi, Pradeep, Jóźwiak, Jacek, Juolevi, Anne, Jurak, Gregor, Jureša, Vesna, Kaaks, Rudolf, Kafatos, Anthony, Kajantie, Eero O., Kalter-Leibovici, Ofra, Kamaruddin, Nor Azmi, Karki, Khem B., Kasaeian, Amir, Katz, Joanne, Kauhanen, Jussi, Kaur, Prabhdeep, Kavousi, Maryam, Kazakbaeva, Gyulli, Keil, Ulrich, Boker, Lital Keinan, Keinänen-Kiukaanniemi, Sirkka, Kelishadi, Roya, Kemper, Han C. G., Kengne, Andre P., Kerimkulova, Alina, Kersting, Mathilde, Key, Timothy, Khader, Yousef Saleh, Khalili, Davood, Khateeb, Mohammad, Khaw, Kay-Tee, Kiechl-Kohlendorfer, Ursula, Kiechl, Stefan, Killewo, Japhet, Kim, Jeongseon, Kim, Yeon-Yong, Klumbiene, Jurate, Knoflach, Michael, Kolle, Elin, Kolsteren, Patrick, Korrovits, Paul, Koskinen, Seppo, Kouda, Katsuyasu, Kowlessur, Sudhir, Koziel, Slawomir, Kriemler, Susi, Kristensen, Peter Lund, Krokstad, Steinar, Kromhout, Daan, Kruger, Herculina S., Kubinova, Ruzena, Kuciene, Renata, Kuh, Diana, Kujala, Urho M., Kulaga, Zbigniew, Krishna Kumar, R., Kurjata, Pawel, Kusuma, Yadlapalli S., Kuulasmaa, Kari, Kyobutungi, Catherine, Laatikainen, Tiina, Lachat, Carl, Lam, Tai Hing, Landrove, Orlando, Lanska, Vera, Lappas, Georg, Larijani, Bagher, Laugsand, Lars E., Le Nguyen Bao, Khanh, Le, Tuyen D., Leclercq, Catherine, Lee, Jeannette, Lee, Jeonghee, Lehtimäki, Terho, León-Muñoz, Luz M., Levitt, Naomi S., Li, Yanping, Lilly, Christa L., Lim, Wei-Yen, Lima-Costa, M. Fernanda, Lin, Hsien-Ho, Lin, Xu, Lind, Lars, Linneberg, Allan, Lissner, Lauren, Litwin, Mieczyslaw, Lorbeer, Roberto, Lotufo, Paulo A., Lozano, José Eugenio, Luksiene, Dalia, Lundqvist, Annamari, Lunet, Nuno, Lytsy, Per, Ma, Guansheng, Ma, Jun, Machado-Coelho, George L. L., Machi, Suka, Maggi, Stefania, Magliano, Dianna J., Magriplis, Emmanuella, Majer, Marjeta, Makdisse, Marcia, Malhotra, Rahul, Mallikharjuna Rao, Kodavanti, Malyutina, Sofia, Manios, Yannis, Mann, Jim I., Manzato, Enzo, Margozzini, Paula, Marques-Vidal, Pedro, Marques, Larissa Pruner, Marrugat, Jaume, Martorell, Reynaldo, Mathiesen, Ellisiv B., Matijasevich, Alicia, Matsha, Tandi E., Mbanya, Jean Claude N., Mc Donald Posso, Anselmo J., McFarlane, Shelly R., McGarvey, Stephen T., McLachlan, Stela, McLean, Rachael M., McLean, Scott B., McNulty, Breige A., Mediene-Benchekor, Sounnia, Medzioniene, Jurate, Meirhaeghe, Aline, Meisinger, Christa, Menezes, Ana Maria B., Menon, Geetha R., Meshram, Indrapal I., Metspalu, Andres, Meyer, Haakon E., Mi, Jie, Mikkel, Kairit, Miller, Jody C., Minderico, Cláudia S., Francisco, Juan, Miranda, J. Jaime, Mirrakhimov, Erkin, Mišigoj-Durakovic, Marjeta, Modesti, Pietro A., Mohamed, Mostafa K., Mohammad, Kazem, Mohammadifard, Noushin, Mohan, Viswanathan, Mohanna, Salim, Mohd Yusoff, Muhammad Fadhli, Møllehave, Line T., Møller, Niels C., Molnár, Dénes, Momenan, Amirabbas, Mondo, Charles K., Monyeki, Kotsedi Daniel K., Moon, Jin Soo, Moreira, Leila B., Morejon, Alain, Moreno, Luis A., Morgan, Karen, Moschonis, George, Mossakowska, Malgorzata, Mostafa, Aya, Mota, Jorge, Esmaeel Motlagh, Mohammad, Motta, Jorge, Msyamboza, Kelias P., Mu, Thet Thet, Muiesan, Maria L., Müller-Nurasyid, Martina, Murphy, Neil, Mursu, Jaakko, Musil, Vera, Nabipour, Iraj, Nagel, Gabriele, Naidu, Balkish M., Nakamura, Harunobu, Námešná, Jana, Nang, Ei Ei K., Nangia, Vinay B., Narake, Sameer, Nauck, Matthias, Navarrete-Muñoz, Eva Maria, Ndiaye, Ndeye Coumba, Neal, William A., Nenko, Ilona, Neovius, Martin, Nervi, Flavio, Nguyen, Chung T., Nguyen, Nguyen D., Nguyen, Quang Ngoc, Nguyen, Quang V., Nieto-Martínez, Ramfis E., Niiranen, Teemu J., Ning, Guang, Ninomiya, Toshiharu, Nishtar, Sania, Noale, Marianna, Noboa, Oscar A., Noorbala, Ahmad Ali, Norat, Teresa, Noto, Davide, Al Nsour, Mohannad, O'Reilly, Dermot, Oda, Eiji, Oehlers, Glenn, Oh, Kyungwon, Ohara, Kumiko, Olinto, Maria Teresa A., Oliveira, Isabel O., Omar, Mohd Azahadi, Onat, Altan, Ong, Sok King, Ono, Lariane M., Ordunez, Pedro, Ornelas, Rui, Osmond, Clive, Ostojic, Sergej M., Ostovar, Afshin, Otero, Johanna A., Overvad, Kim, Owusu-Dabo, Ellis, Paccaud, Fred Michel, Padez, Cristina, Pahomova, Elena, Pajak, Andrzej, Palli, Domenico, Palmieri, Luigi, Pan, Wen-Harn, Panda-Jonas, Songhomitra, Panza, Francesco, Papandreou, Dimitrios, Park, Soon-Woo, Parnell, Winsome R., Parsaeian, Mahboubeh, Patel, Nikhil D., Pecin, Ivan, Pednekar, Mangesh S., Peer, Nasheeta, Peeters, Petra H., Peixoto, Sergio Viana, Peltonen, Markku, Pereira, Alexandre C., Peters, Annette, Petersmann, Astrid, Petkeviciene, Janina, Pham, Son Thai, Pigeot, Iris, Pikhart, Hynek, Pilav, Aida, Pilotto, Lorenza, Pitakaka, Freda, Piwonska, Aleksandra, Plans-Rubió, Pedro, Polašek, Ozren, Porta, Miquel, Portegies, Marileen L. P., Pourshams, Akram, Poustchi, Hossein, Pradeepa, Rajendra, Prashant, Mathur, Price, Jacqueline F., Puder, Jardena J., Puiu, Maria, Punab, Margus, Qasrawi, Radwan F., Qorbani, Mostafa, Bao, Tran Quoc, Radic, Ivana, Radisauskas, Ricardas, Rahman, Mahfuzar, Raitakari, Olli, Raj, Manu, Ramachandra Rao, Sudha, Ramachandran, Ambady, Ramos, Elisabete, Rampal, Lekhraj, Rampal, Sanjay, Rangel Reina, Daniel A., Redon, Josep, Reganit, Paul Ferdinand M., Ribeiro, Robespierre, Riboli, Elio, Rigo, Fernando, Rinke de Wit, Tobias F., Ritti-Dias, Raphael M., Robinson, Sian M., Robitaille, Cynthia, Rodríguez-Artalejo, Fernando, del Cristo Rodriguez-Perez, María, Rodríguez-Villamizar, Laura A., Rojas-Martinez, Rosalba, Romaguera, Dora, Ronkainen, Kimmo, Rosengren, Annika, Roy, Joel G. R., Rubinstein, Adolfo, Sandra Ruiz-Betancourt, Blanca, Rutkowski, Marcin, Sabanayagam, Charumathi, Sachdev, Harshpal S., Saidi, Olfa, Sakarya, Sibel, Salanave, Benoit, Salazar Martinez, Eduardo, Salmerón, Diego, Salomaa, Veikko, Salonen, Jukka T., Salvetti, Massimo, Sánchez-Abanto, Jose, Sans, Susana, Santos, Diana A., Santos, Ina S., Nunes dos Santos, Renata, Santos, Rute, Saramies, Jouko L., Sardinha, Luis B., Sarganas, Giselle, Sarrafzadegan, Nizal, Saum, Kai-Uwe, Savva, Savvas, Scazufca, Marcia, Schargrodsky, Herman, Schipf, Sabine, Schmidt, Carsten O., Schöttker, Ben, Schultsz, Constance, Schutte, Aletta E., Sein, Aye Aye, Sen, Abhijit, Senbanjo, Idowu O., Sepanlou, Sadaf G., Sharma, Sanjib K., Shaw, Jonathan E., Shibuya, Kenji, Shin, Dong Wook, Shin, Youchan, Si-Ramlee, Khairil, Siantar, Rosalynn, Sibai, Abla M., Santos Silva, Diego Augusto, Simon, Mary, Simons, Judith, Simons, Leon A., Sjöström, Michael, Skovbjerg, Sine, Slowikowska-Hilczer, Jolanta, Slusarczyk, Przemyslaw, Smeeth, Liam, Smith, Margaret C., Snijder, Marieke B., So, Hung-Kwan, Sobngwi, Eugène, Söderberg, Stefan, Solfrizzi, Vincenzo, Sonestedt, Emily, Song, Yi, Sørensen, Thorkild I. A., Soric, Maroje, Jérome, Charles Sossa, Soumare, Aicha, Staessen, Jan A., Stathopoulou, Maria G., Stavreski, Bill, Steene-Johannessen, Jostein, Stehle, Peter, Stein, Aryeh D., Stergiou, George S., Stessman, Jochanan, Stieber, Jutta, Stöckl, Doris, Stocks, Tanja, Stokwiszewski, Jakub, Stronks, Karien, Strufaldi, Maria Wany, Sun, Chien-An, Sung, Yn-Tz, Suriyawongpaisal, Paibul, Sy, Rody G., Shyong Tai, E., Tammesoo, Mari-Liis, Tamosiunas, Abdonas, Tan, Eng Joo, Tang, Xun, Tanser, Frank, Tao, Yong, Tarawneh, Mohammed Rasoul, Tarqui-Mamani, Carolina B., Tautu, Oana-Florentina, Taylor, Anne, Theobald, Holger, Theodoridis, Xenophon, Thijs, Lutgarde, Thuesen, Betina H., Tjonneland, Anne, Tolonen, Hanna K., Tolstrup, Janne S., Topbas, Murat, Topór-Madry, Roman, Tormo, María José, Torrent, Maties, Traissac, Pierre, Trichopoulos, Dimitrios, Trichopoulou, Antonia, Trinh, Oanh T. H., Trivedi, Atul, Tshepo, Lechaba, Tulloch-Reid, Marshall K., Tullu, Fikru, Tuomainen, Tomi-Pekka, Tuomilehto, Jaakko, Turley, Maria L., Tynelius, Per, Tzourio, Christophe, Ueda, Peter, Ugel, Eunice E., Ulmer, Hanno, Uusitalo, Hannu M. T., Valdivia, Gonzalo, Valvi, Damaskini, van der Schouw, Yvonne T., Van Herck, Koen, Van Minh, Hoang, van Rossem, Lenie, Van Schoor, Natasja M., van Valkengoed, Irene G. M., Vanderschueren, Dirk, Vanuzzo, Diego, Vatten, Lars, Vega, Tomas, Velasquez-Melendez, Gustavo, Veronesi, Giovanni, Monique Verschuren, W. M., Verstraeten, Roosmarijn, Victora, Cesar G., Viet, Lucie, Viikari-Juntura, Eira, Vineis, Paolo, Vioque, Jesus, Virtanen, Jyrki K., Visvikis-Siest, Sophie, Viswanathan, Bharathi, Vlasoff, Tiina, Vollenweider, Peter, Voutilainen, Sari, Wade, Alisha N., Wagner, Aline, Walton, Janette, Wan Bebakar, Wan Mohamad, Wan Mohamud, Wan Nazaimoon, Wanderley, Rildo S., Wang, Ming-Dong, Wang, Qian, Wang, Ya Xing, Wang, Ying-Wei, Wannamethee, S. Goya, Wareham, Nicholas, Wedderkopp, Niels, Weerasekera, Deepa, Whincup, Peter H., Widhalm, Kurt, Widyahening, Indah S., Wiecek, Andrzej, Wijga, Alet H., Wilks, Rainford J., Willeit, Johann, Willeit, Peter, Williams, Emmanuel A., Wilsgaard, Tom, Wojtyniak, Bogdan, Wong-McClure, Roy A., Wong, Justin Y. Y., Wong, Tien Yin, Woo, Jean, Giwercman Wu, Aleksander, Wu, Frederick C., Wu, Shouling, Xu, Haiquan, Yan, Weili, Yang, Xiaoguang, Ye, Xingwang, Yoshihara, Akihiro, Younger-Coleman, Novie O., Yusoff, Ahmad Faudzi, Zainuddin, Ahmad Ali, Zambon, Sabina, Zampelas, Antonis, Zdrojewski, Tomasz, Zeng, Yi, Zhao, Dong, Zhao, Wenhua, Zheng, Wei, Zheng, Yingfeng, Zhu, Dan, Zhussupov, Baurzhan, Zimmermann, Esther, Cisneros, Julio Zuñiga, Imperial Coll London, Univ Kent, Middlesex Univ, Harvard TH Chan, Cleveland Clin, Univ Peruana Cayetano Heredia, Univ Tehran Med Sci, Minist Hlth & Med Educ, Brandeis Univ, Mulago Hosp, Uganda Heart Inst, World Hlth Org, Univ Oxford, Univ West Indies, Univ Auckland, South African Med Res Council, Seoul Natl Univ, Natl Inst Nutr, Capital Med Univ, Robert Koch Inst, German Ctr Cardiovasc Res, Univ Zagreb, Univ Ljubljana, Uppsala Univ, Univ New South Wales, Caja Costarricense Seguro Social, Al Quds Univ, Birzeit Univ, Inst Mexicano Seguro Social, Univ Adelaide, Mahidol Univ, BRAC, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Univ Amsterdam, Minist Hlth Malaysia, Non Communicable Dis Res Ctr, BIPS, Natl Ctr Diabet & Endocrinol, Kazakh Natl Med Univ, King Abdulaziz Univ, Univ Malaysia Sabah, Luxembourg Inst Hlth, World Hlth Org Reg Off Eastern Mediterranean, Bombay Hosp & Med Res Ctr, Med Res Ctr, Lille Univ & Hosp, London Sch Hyg Trop Med, Western Norway Univ Appl Sci, Norwegian Sch Sport Sci, Bispebjerg Hosp, Frederiksberg Univ Hosp, Madras Diabet Res Fdn, Komfo Anokye Teaching Hosp, Natl Inst Publ Hlth, Univ Porto, Norwegian Inst Publ Hlth, Strasbourg Univ & Hosp, Nepal Hlth Res Council, Univ Iceland, Univ Yaounde I, Univ Fed Pelotas, Reg Author Publ Hlth, Shahid Beheshti Univ Med Sci, Indian Council Med Res, Univ Sci & Technol, Univ Autonoma Madrid, Univ Palermo, Pan Amer Hlth Org, Univ Mohammed V Rabat, Univ Pernambuco, Dalhousie Univ, Jordan Univ Sci & Technol, Univ Sydney, Univ Tunis El Manar, CAFAM Univ Fdn, Univ Utah, Lithuanian Univ Hlth Sci, Universidade de São Paulo (USP), BJ Med Coll, Chirayu Med Coll, SL Jain Hosp, Shanghai Jiao Tong Univ, Ufa Eye Res Inst, Univ Southern, Univ Greenland, Univ Oslo, Univ Gothenburg, Natl Inst Publ Hlth & Environm, Univ Turin, UCL, German Inst Human Nutr, Univ Republica, CEMIC, Toulouse Univ, Univ Hosp Varese, Minist Hlth, Univ Lausanne, Univ Ghent, Univ Cent Venezuela, Bielefeld Univ, German Canc Res Ctr, Univ Southern Denmark, Cork Inst Technol, Hadassah Hebrew Univ, Univ La Laguna, Univ Malta, Vanderbilt Univ, Canadian Fitness & Lifestyle Res Inst, Istanbul Univ, Univ Fed Juiz De Fora, Cardiol Mercato S Severino, Karolinska Inst, Univ Santiago Compostela, Duke NUS Med Sch, Natl Inst Med Stat, Acad Sinica, Capital Inst Pediat, Duke Univ, Kailuan Gen Hosp, Gertner Inst Epidemiol & Hlth Policy Res, Univ Bern, Minist Hlth & Welf, Victor Babes Univ Med & Pharm Timisoara, Murcia Reg Hlth Council, Korea Centers Dis Control & Prevent, Universidade Estadual Paulista (Unesp), Med Univ Silesia, Charles Univ Prague, Carol Davila Univ Med & Pharm, Katholieke Univ Leuven, Agcy Prevent & Social Med, Univ Southampton, IRCCS Ist Neurol Mediterraneo Neuromed, Inst Pasteur, CIBEROBN, Natl Council Res, Universidade Federal de Santa Catarina (UFSC), Eduardo Mondlane Univ, Bispebjerg & Frederiksberg Hosp, Erasmus MC, Univ Montreal, French Publ Hlth Agcy, Univ Do Vale Do Rio Dos Sinos, Natl Council Sci & Tech Res, Univ Queensland, Ist Super Sanita, Univ Cuenca, Helmholtz Zentrum Munchen, Minist Sante & Lutte Contre Sida, Cardinal Wyszynski Inst Cardiol, Univ Latvia, Natl Inst Nutr & Food Technol, Inst Hosp Del Mar dInvest Med, Univ Stellenbosch, Karadeniz Tech Univ, Natl Inst Hlth & Welf, Queens Univ Belfast, Univ Zurich, Centro Salud Villanueva Norte, Hosp Don Benito Villanueva Serena, Council Agr Res & Econ, Pontificia Univ Catolica Chile, Univ Manchester, Univ Tartu, Univ Sains Malaysia, Umea Univ, Dalarna Univ, Universidade Federal de São Paulo (UNIFESP), Hosp Univ Son Espases, Hosp Clin Porto Alegre, Univ Fed Rio Grande, Kindai Univ, Kyoto Univ, Med Univ Warsaw, Univ Catania, CIBER Epidemiol & Salud Publ, Univ KwaZulu Natal, Geneva Univ Hosp, Australian Bur Stat, Wageningen Univ, B P Koirala Inst Hlth Sci, Univ Insubria, Univ Politecn Madrid, Andes Clin Cardio Metab Studies, Natl Inst Hyg Epidemiol & Microbiol, Univ Lille 2, Inst Clin & Expt Med, Childrens Mem Hlth Inst, Alexander Technol Educ Inst, Jagiellonian Univ, Azienda Ospedaliera Univ Policlinico Vittorio Ema, Univ Novi Sad, Natl Ctr Cardiovasc Dis, Singapore Eye Res Inst, Iceland Heart Assoc, Univ Icesi, Univ Estadual Montes Claros, Kings Coll London, Int Agcy Res Canc, Healis Sekhsaria Inst Publ Hlth, Eternal Heart Care Ctr & Res Inst, Univ Ibadan, Inst Clin Effectiveness & Hlth Policy, Danish Canc Soc Res Ctr, Kyushu Univ, Tulane Univ, Chinese Ctr Dis Control & Prevent, Oulu Univ Hosp, Chron Dis Res Ctr, Univ Hong Kong, Chinese Univ Hong Kong, Univ Western Australia, Celal Bayar Univ, Fdn Oftalmol Santander, Univ Oran 1, Independent Publ Hlth Specialist, Peking Univ, Vrije Univ Amsterdam, Amer Univ Beirut, Cairo Univ, Aga Khan Univ, UHC Zagreb, Niigata Univ, Hadassah Univ Med Ctr, Norwegian Univ Sci & Technol, Heart Fdn, Natl Hlth Insurance Serv, Guangzhou 12th Hosp, Simon Fraser Univ, Heidelberg Univ, Res Ctr Prevent & Hlth, World Hlth Org Country Off, Czestochowa Tech Univ, Univ Crete, Univ Kebangsaan Malaysia, Johns Hopkins Bloomberg Sch Publ Hlth, Univ Eastern Finland, Natl Inst Epidemiol, Univ Munster, Israel Ctr Dis Control, Res Inst Primordial Prevent Non communicable Dis, Kyrgyz State Med Acad, Res Inst Child Nutr, Univ Cambridge, Med Univ Innsbruck, Muhimbili Univ Hlth & Allied Sci, Natl Canc Ctr, Inst Trop Med, Tartu Univ Clin, Minist Hlth & Qual Life, Polish Acad Sci, Univ Groningen, North West Univ, Univ Jyvaskyla, Amrita Inst Med Sci, All India Inst Med Sci, African Populat & Hlth Res Ctr, Minist Salud Publ, Sahlgrens Acad, Endocrinol & Metab Res Ctr, Food & Agr Org United Nat, Natl Univ Singapore, Tampere Univ Hosp, Univ Cape Town, West Virginia Univ, Oswaldo Cruz Fdn Rene Rachou Res Inst, Natl Taiwan Univ, Univ Chinese Acad Sci, Univ Med Greifswald, Consejeria Sanidad Junta de Castilla & Leon, Univ Fed Ouro Preto, Jikei Univ, CNR, Baker Heart & Diabet Inst, Agr Univ Athens, Hosp Israelita Albert Einstein, Shiraz Univ Med Sci, Inst Internal & Prevent Med, Harokopio Univ, Univ Otago, Univ Padua, Lausanne Univ Hosp, CIBERCV, Emory Univ, UiT Arctic Univ Norway, Cape Peninsula Univ Technol, Gorgas Mem Inst Hlth Studies, Brown Univ, Univ Edinburgh, Stat Canada, Univ Coll Dublin, INSERM, Lusofona Univ, Univ Firenze, Ain Shams Univ, Hypertens Res Ctr, Univ Pecs, Univ Limpopo, Univ Fed Rio Grande do Sul, Univ Med Sci, Univ Zaragoza, RCSI Dublin, La Trobe Univ, Int Inst Mol & Cell Biol, Ahvaz Jundishapur Univ Med Sci, Gorgas Mem Inst Publ Hlth, WHO, Dept Publ Hlth, Univ Brescia, Bushehr Univ Med Sci, Ulm Univ, Kobe Univ, Suraj Eye Inst, German Ctr Cardiovascular Res, Natl Inst Hyg & Epidemiol, Univ Pharm & Med Ho Chi Minh City, Hanoi Med Univ, Natl Hosp Endocrinol, Miami Vet Affairs Healthcare Syst, Univ Turku Tyks, Heartfile, Eastern Mediterranean Publ Hlth Network, Tachikawa Gen Hosp, Acad Hosp Paramaribo, Korea Ctr Dis Control & Prevent, Univ Vale Rio dos Sinos, Univ Madeira, MRC Lifecourse Epidemiol Unit, Aarhus Univ, Kwame Nkrumah Univ Sci & Technol, Nstitute Social & Prevent Med, Univ Coimbra, Canc Prevent & Res Inst, IRCCS Casa Sollievo Sofferenza, Zayed Univ, Catholic Univ Daegu, Jivandeep Hosp, Univ Hosp Ctr Zagreb, Univ Med Ctr Utrecht, Fundacao Oswaldo Cruz, Vietnam Natl Heart Inst, Leibniz Inst Prevent Res & Epidemiol BIPS, Univ Sarajevo, Cardiovasc Prevent Ctr, Minist Hlth & Med Serv, Publ Hlth Agcy Catalonia, Univ Split, Inst Hosp Mar Invest Med, Digest Oncol Res Ctr, Digest Dis Res Inst, Alborz Univ Med Sci, Univ Turku, India Diabet Res Fdn, Univ Putra Malaysia, Univ Malaya, Univ Valencia, Univ Philippines, Minas Gerais State Secretariat Hlth, Hlth Ctr San Agustin, PharmAccess Fdn, Univ Nove de Julho, Publ Hlth Agcy Canada, Canarian Hlth Serv, Univ Ind Santander, Inst Nacl Salud Publ, Med Univ Gdansk, Sitaram Bhartia Inst Sci & Res, Marmara Univ, Univ Helsinki, Natl Inst Hlth, Catalan Dept Hlth, Univ Lisbon, South Karelia Social & Hlth Care Dist, Isfahan Cardiovasc Res Ctr, Res & Educ Inst Child Hlth, Hosp Italiano Buenos Aires, Lagos State Univ, BP Koirala Inst Hlth Sci, Univ Tokyo, Samsung Med Ctr, St Vincents Hosp, Med Univ Lodz, London Sch Hyg & Trop Med, Acad Med Ctr, Univ Bari, Lund Univ, Univ Copenhagen, Inst Reg Sante Publ, Univ Bordeaux, Univ Leuven, Univ Bonn, Sotiria Hosp, Hadassah Univ, Natl Inst Hyg, Fu Jen Catholic Univ, Hlth Serv Murcia, IB SALUT Area Salut Menorca, Inst Rech Dev, Harvard TH Chan Sch Publ Hlth, Hellen Hlth Fdn, Govt Med Coll, Sefako Makgatho Hlth Sci Univ, Addis Ababa Univ, Dasman Diabet Inst, Univ Centrooccidental Lisandro Alvarado, Univ Tampere, Univ Utrecht, Hanoi Univ Publ Hlth, Amsterdam Publ Hlth Res Inst, Consejeria Sanidad Junta Castilla & Leon, Universidade Federal de Minas Gerais (UFMG), Finnish Inst Occupat Hlth, Univ Miguel Hernandez, North Karelian Ctr Publ Hlth, Univ Witwatersrand, Univ Strasbourg, Inst Med Res, Xinjiang Med Univ, St Georges Univ London, Med Univ Vienna, Univ Indonesia, Minist Agr, Fudan Univ, Univ Cyprus, Univ Teknol MARA, Inner Mongolia Med Univ, Zhou, B., Bentham, J., Di Cesare, M., Bixby, H., Danaei, G., Hajifathalian, K., Taddei, C., Carrillo-Larco, R.M., Djalalinia, S., Khatibzadeh, S., Lugero, C., Peykari, N., Zhang, W.Z., Bennett, J., Bilano, V., Stevens, G.A., Cowan, M.J., Riley, L.M., Chen, Z., Hambleton, I.R., Jackson, R.T., Kengne, A.P., Khang, Y.H., Laxmaiah, A., Liu, J., Malekzadeh, R., Neuhauser, H.K., Sorić, M., Starc, G., Sundström, J., Woodward, M., Ezzati, M., Abarca-Gómez, L., Abdeen, Z.A., Abu-Rmeileh, N.M., Acosta-Cazares, B., Adams, R.J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C.A., Agyemang, C., Ahmad, N.A., Ahmadvand, A., Ahrens, W., Ajlouni, K., Akhtaeva, N., Al-Raddadi, R., Ali, M.M., Ali, O., Alkerwi, A., Aly, E., Amarapurkar, D.N., Amouyel, P., Amuzu, A., Andersen, L.B., Anderssen, S.A., Ängquist, L.H., Anjana, R.M., Ansong, D., Aounallah-Skhiri, H., Araújo, J., Ariansen, I., Aris, T., Arlappa, N., Arveiler, D., Aryal, K.K., Aspelund, T., Assah, F.K., Assunção, MCF, Avdicová, M., Azevedo, A., Azizi, F., Babu, B.V., Bahijri, S., Balakrishna, N., Bamoshmoosh, M., Banach, M., Bandosz, P., Banegas, J.R., Barbagallo, C.M., Barceló, A., Barkat, A., Barros, AJD, Barros, M.V., Bata, I., Batieha, A.M., Batyrbek, A., Baur, L.A., Beaglehole, R., Romdhane, H.B., Benet, M., Benson, L.S., Bernabe-Ortiz, A., Bernotiene, G., Bettiol, H., Bhagyalaxmi, A., Bharadwaj, S., Bhargava, S.K., Bi, Y., Bikbov, M., Bista, B., Bjerregaard, P., Bjertness, E., Bjertness, M.B., Björkelund, C., Blokstra, A., Bo, S., Bobak, M., Boeing, H., Boggia, J.G., Boissonnet, C.P., Bongard, V., Borchini, R., Bovet, P., Braeckman, L., Brajkovich, I., Branca, F., Breckenkamp, J., Brenner, H., Brewster, L.M., Bruno, G., Bueno-de-Mesquita, HBA, Bugge, A., Burns, C., Bursztyn, M., de León, A.C., Cacciottolo, J., Cai, H., Cameron, C., Can, G., Cândido, APC, Capuano, V., Cardoso, V.C., Carlsson, A.C., Carvalho, M.J., Casanueva, F.F., Casas, J.P., Caserta, C.A., Chamukuttan, S., Chan, A.W., Chan, Q., Chaturvedi, H.K., Chaturvedi, N., Chen, C.J., Chen, F., Chen, H., Chen, S., Cheng, C.Y., Dekkaki, I.C., Chetrit, A., Chiolero, A., Chiou, S.T., Chirita-Emandi, A., Chirlaque, M.D., Cho, B., Cho, Y., Christofaro, D.G., Chudek, J., Cifkova, R., Cinteza, E., Claessens, F., Clays, E., Concin, H., Cooper, C., Cooper, R., Coppinger, T.C., Costanzo, S., Cottel, D., Cowell, C., Craig, C.L., Crujeiras, A.B., Cruz, J.J., D'Arrigo, G., d'Orsi, E., Dallongeville, J., Damasceno, A., Dankner, R., Dantoft, T.M., Dauchet, L., Davletov, K., De Backer, G., De Bacquer, D., de Gaetano, G., De Henauw, S., de Oliveira, P.D., De Smedt, D., Deepa, M., Dehghan, A., Delisle, H., Deschamps, V., Dhana, K., Di Castelnuovo, A.F., Dias-da-Costa, J.S., Diaz, A., Dickerson, T.T., Do, HTP, Donfrancesco, C., Donoso, S.P., Döring, A., Dorobantu, M., Doua, K., Drygas, W., Dulskiene, V., Džakula, A., Dzerve, V., Dziankowska-Zaborszczyk, E., Eggertsen, R., Ekelund, U., El Ati, J., Elliott, P., Elosua, R., Erasmus, R.T., Erem, C., Eriksen, L., Eriksson, J.G., Escobedo-de la Peña, J., Evans, A., Faeh, D., Fall, C.H., Farzadfar, F., Felix-Redondo, F.J., Ferguson, T.S., Fernandes, R.A., Fernández-Bergés, D., Ferrante, D., Ferrari, M., Ferreccio, C., Ferrieres, J., Finn, J.D., Fischer, K., Föger, B., Foo, L.H., Forslund, A.S., Forsner, M., Fouad, H.M., Francis, D.K., do Carmo Franco, M., Franco, O.H., Frontera, G., Fuchs, F.D., Fuchs, S.C., Fujita, Y., Furusawa, T., Gaciong, Z., Galvano, F., Garcia-de-la-Hera, M., Gareta, D., Garnett, S.P., Gaspoz, J.M., Gasull, M., Gates, L., Geleijnse, J.M., Ghasemian, A., Ghimire, A., Giampaoli, S., Gianfagna, F., Gill, T.K., Giovannelli, J., Goldsmith, R.A., Gonçalves, H., Gonzalez-Gross, M., González-Rivas, J.P., Gorbea, M.B., Gottrand, F., Graff-Iversen, S., Grafnetter, D., Grajda, A., Grammatikopoulou, M.G., Gregor, R.D., Grodzicki, T., Grøntved, A., Grosso, G., Gruden, G., Grujic, V., Gu, D., Guan, O.P., Gudmundsson, E.F., Gudnason, V., Guerrero, R., Guessous, I., Guimaraes, A.L., Gulliford, M.C., Gunnlaugsdottir, J., Gunter, M., Gupta, P.C., Gupta, R., Gureje, O., Gurzkowska, B., Gutierrez, L., Gutzwiller, F., Hadaegh, F., Halkjær, J., Hardy, R., Hari Kumar, R., Hata, J., Hayes, A.J., He, J., He, Y., Elisabeth, M., Henriques, A., Cadena, L.H., Herrala, S., Heshmat, R., Hihtaniemi, I.T., Ho, S.Y., Ho, S.C., Hobbs, M., Hofman, A., Dinc, G.H., Horimoto, ARVR, Hormiga, C.M., Horta, B.L., Houti, L., Howitt, C., Htay, T.T., Htet, A.S., Than Htike, M.M., Hu, Y., Huerta, J.M., Huisman, M., Husseini, A.S., Huybrechts, I., Hwalla, N., Iacoviello, L., Iannone, A.G., Ibrahim, M.M., Wong, N.I., Ikeda, N., Ikram, M.A., Irazola, V.E., Islam, M., Al-Safi Ismail, A., Ivkovic, V., Iwasaki, M., Jacobs, J.M., Jaddou, H., Jafar, T., Jamrozik, K., Janszky, I., Jasienska, G., Jelaković, A., Jelaković, B., Jennings, G., Jeong, S.L., Jiang, C.Q., Joffres, M., Johansson, M., Jokelainen, J.J., Jonas, J.B., Jørgensen, T., Joshi, P., Jóźwiak, J., Juolevi, A., Jurak, G., Jureša, V., Kaaks, R., Kafatos, A., Kajantie, E.O., Kalter-Leibovici, O., Kamaruddin, N.A., Karki, K.B., Kasaeian, A., Katz, J., Kauhanen, J., Kaur, P., Kavousi, M., Kazakbaeva, G., Keil, U., Boker, L.K., Keinänen-Kiukaanniemi, S., Kelishadi, R., Kemper, HCG, Kerimkulova, A., Kersting, M., Key, T., Khader, Y.S., Khalili, D., Khateeb, M., Khaw, K.T., Kiechl-Kohlendorfer, U., Kiechl, S., Killewo, J., Kim, J., Kim, Y.Y., Klumbiene, J., Knoflach, M., Kolle, E., Kolsteren, P., Korrovits, P., Koskinen, S., Kouda, K., Kowlessur, S., Koziel, S., Kriemler, S., Kristensen, P.L., Krokstad, S., Kromhout, D., Kruger, H.S., Kubinova, R., Kuciene, R., Kuh, D., Kujala, U.M., Kulaga, Z., Krishna Kumar, R., Kurjata, P., Kusuma, Y.S., Kuulasmaa, K., Kyobutungi, C., Laatikainen, T., Lachat, C., Lam, T.H., Landrove, O., Lanska, V., Lappas, G., Larijani, B., Laugsand, L.E., Le Nguyen Bao, K., Le, T.D., Leclercq, C., Lee, J., Lehtimäki, T., León-Muñoz, L.M., Levitt, N.S., Li, Y., Lilly, C.L., Lim, W.Y., Lima-Costa, M.F., Lin, H.H., Lin, X., Lind, L., Linneberg, A., Lissner, L., Litwin, M., Lorbeer, R., Lotufo, P.A., Lozano, J.E., Luksiene, D., Lundqvist, A., Lunet, N., Lytsy, P., Ma, G., Ma, J., Machado-Coelho, GLL, Machi, S., Maggi, S., Magliano, D.J., Magriplis, E., Majer, M., Makdisse, M., Malhotra, R., Mallikharjuna Rao, K., Malyutina, S., Manios, Y., Mann, J.I., Manzato, E., Margozzini, P., Marques-Vidal, P., Marques, L.P., Marrugat, J., Martorell, R., Mathiesen, E.B., Matijasevich, A., Matsha, T.E., Mbanya, JCN, Mc Donald Posso, A.J., McFarlane, S.R., McGarvey, S.T., McLachlan, S., McLean, R.M., McLean, S.B., McNulty, B.A., Mediene-Benchekor, S., Medzioniene, J., Meirhaeghe, A., Meisinger, C., Menezes, AMB, Menon, G.R., Meshram, I.I., Metspalu, A., Meyer, H.E., Mi, J., Mikkel, K., Miller, J.C., Minderico, C.S., Francisco, J., Miranda, J.J., Mirrakhimov, E., Mišigoj-Durakovic, M., Modesti, P.A., Mohamed, M.K., Mohammad, K., Mohammadifard, N., Mohan, V., Mohanna, S., Mohd Yusoff, M.F., Møllehave, L.T., Møller, N.C., Molnár, D., Momenan, A., Mondo, C.K., Monyeki, KDK, Moon, J.S., Moreira, L.B., Morejon, A., Moreno, L.A., Morgan, K., Moschonis, G., Mossakowska, M., Mostafa, A., Mota, J., Esmaeel Motlagh, M., Motta, J., Msyamboza, K.P., Mu, T.T., Muiesan, M.L., Müller-Nurasyid, M., Murphy, N., Mursu, J., Musil, V., Nabipour, I., Nagel, G., Naidu, B.M., Nakamura, H., Námešná, J., Nang, EEK, Nangia, V.B., Narake, S., Nauck, M., Navarrete-Muñoz, E.M., Ndiaye, N.C., Neal, W.A., Nenko, I., Neovius, M., Nervi, F., Nguyen, C.T., Nguyen, N.D., Nguyen, Q.N., Nguyen, Q.V., Nieto-Martínez, R.E., Niiranen, T.J., Ning, G., Ninomiya, T., Nishtar, S., Noale, M., Noboa, O.A., Noorbala, A.A., Norat, T., Noto, D., Al Nsour, M., O'Reilly, D., Oda, E., Oehlers, G., Oh, K., Ohara, K., Olinto, MTA, Oliveira, I.O., Omar, M.A., Onat, A., Ong, S.K., Ono, L.M., Ordunez, P., Ornelas, R., Osmond, C., Ostojic, S.M., Ostovar, A., Otero, J.A., Overvad, K., Owusu-Dabo, E., Paccaud, F.M., Padez, C., Pahomova, E., Pajak, A., Palli, D., Palmieri, L., Pan, W.H., Panda-Jonas, S., Panza, F., Papandreou, D., Park, S.W., Parnell, W.R., Parsaeian, M., Patel, N.D., Pecin, I., Pednekar, M.S., Peer, N., Peeters, P.H., Peixoto, S.V., Peltonen, M., Pereira, A.C., Peters, A., Petersmann, A., Petkeviciene, J., Pham, S.T., Pigeot, I., Pikhart, H., Pilav, A., Pilotto, L., Pitakaka, F., Piwonska, A., Plans-Rubió, P., Polašek, O., Porta, M., Portegies, MLP, Pourshams, A., Poustchi, H., Pradeepa, R., Prashant, M., Price, J.F., Puder, J.J., Puiu, M., Punab, M., Qasrawi, R.F., Qorbani, M., Bao, T.Q., Radic, I., Radisauskas, R., Rahman, M., Raitakari, O., Raj, M., Ramachandra Rao, S., Ramachandran, A., Ramos, E., Rampal, L., Rampal, S., Rangel Reina, D.A., Redon, J., Reganit, PFM, Ribeiro, R., Riboli, E., Rigo, F., Rinke de Wit, T.F., Ritti-Dias, R.M., Robinson, S.M., Robitaille, C., Rodríguez-Artalejo, F., Del Cristo Rodriguez-Perez, M., Rodríguez-Villamizar, L.A., Rojas-Martinez, R., Romaguera, D., Ronkainen, K., Rosengren, A., Roy, JGR, Rubinstein, A., Sandra Ruiz-Betancourt, B., Rutkowski, M., Sabanayagam, C., Sachdev, H.S., Saidi, O., Sakarya, S., Salanave, B., Salazar Martinez, E., Salmerón, D., Salomaa, V., Salonen, J.T., Salvetti, M., Sánchez-Abanto, J., Sans, S., Santos, D.A., Santos, I.S., Nunes Dos Santos, R., Santos, R., Saramies, J.L., Sardinha, L.B., Sarganas, G., Sarrafzadegan, N., Saum, K.U., Savva, S., Scazufca, M., Schargrodsky, H., Schipf, S., Schmidt, C.O., Schöttker, B., Schultsz, C., Schutte, A.E., Sein, A.A., Sen, A., Senbanjo, I.O., Sepanlou, S.G., Sharma, S.K., Shaw, J.E., Shibuya, K., Shin, D.W., Shin, Y., Si-Ramlee, K., Siantar, R., Sibai, A.M., Santos Silva, D.A., Simon, M., Simons, J., Simons, L.A., Sjöström, M., Skovbjerg, S., Slowikowska-Hilczer, J., Slusarczyk, P., Smeeth, L., Smith, M.C., Snijder, M.B., So, H.K., Sobngwi, E., Söderberg, S., Solfrizzi, V., Sonestedt, E., Song, Y., Sørensen, TIA, Soric, M., Jérome, C.S., Soumare, A., Staessen, J.A., Stathopoulou, M.G., Stavreski, B., Steene-Johannessen, J., Stehle, P., Stein, A.D., Stergiou, G.S., Stessman, J., Stieber, J., Stöckl, D., Stocks, T., Stokwiszewski, J., Stronks, K., Strufaldi, M.W., Sun, C.A., Sung, Y.T., Suriyawongpaisal, P., Sy, R.G., Shyong Tai, E., Tammesoo, M.L., Tamosiunas, A., Tan, E.J., Tang, X., Tanser, F., Tao, Y., Tarawneh, M.R., Tarqui-Mamani, C.B., Tautu, O.F., Taylor, A., Theobald, H., Theodoridis, X., Thijs, L., Thuesen, B.H., Tjonneland, A., Tolonen, H.K., Tolstrup, J.S., Topbas, M., Topór-Madry, R., Tormo, M.J., Torrent, M., Traissac, P., Trichopoulos, D., Trichopoulou, A., Trinh, OTH, Trivedi, A., Tshepo, L., Tulloch-Reid, M.K., Tullu, F., Tuomainen, T.P., Tuomilehto, J., Turley, M.L., Tynelius, P., Tzourio, C., Ueda, P., Ugel, E.E., Ulmer, H., Uusitalo, HMT, Valdivia, G., Valvi, D., van der Schouw, Y.T., Van Herck, K., Van Minh, H., van Rossem, L., Van Schoor, N.M., van Valkengoed, IGM, Vanderschueren, D., Vanuzzo, D., Vatten, L., Vega, T., Velasquez-Melendez, G., Veronesi, G., Monique Verschuren, W.M., Verstraeten, R., Victora, C.G., Viet, L., Viikari-Juntura, E., Vineis, P., Vioque, J., Virtanen, J.K., Visvikis-Siest, S., Viswanathan, B., Vlasoff, T., Vollenweider, P., Voutilainen, S., Wade, A.N., Wagner, A., Walton, J., Wan Bebakar, W.M., Wan Mohamud, W.N., Wanderley, R.S., Wang, M.D., Wang, Q., Wang, Y.X., Wang, Y.W., Wannamethee, S.G., Wareham, N., Wedderkopp, N., Weerasekera, D., Whincup, P.H., Widhalm, K., Widyahening, I.S., Wiecek, A., Wijga, A.H., Wilks, R.J., Willeit, J., Willeit, P., Williams, E.A., Wilsgaard, T., Wojtyniak, B., Wong-McClure, R.A., Wong, JYY, Wong, T.Y., Woo, J., Giwercman Wu, A., Wu, F.C., Wu, S., Xu, H., Yan, W., Yang, X., Ye, X., Yiallouros, P.K., Yoshihara, A., Younger-Coleman, N.O., Yusoff, A.F., Zainuddin, A.A., Zambon, S., Zampelas, A., Zdrojewski, T., Zeng, Y., Zhao, D., Zhao, W., Zheng, W., Zheng, Y., Zhu, D., Zhussupov, B., Zimmermann, E., Cisneros, J.Z., Zhou, Bin, Bentham, Jame, Di Cesare, Mariachiara, Bixby, Honor, Danaei, Goodarz, Hajifathalian, Kaveh, Taddei, Cristina, Carrillo-Larco, Rodrigo M, Djalalinia, Shirin, Khatibzadeh, Shahab, Lugero, Charle, Peykari, Niloofar, Zhang, Wan Zhu, Bennett, Jame, Bilano, Ver, Stevens, Gretchen A, Cowan, Melanie J, Riley, Leanne M, Chen, Zhengming, Hambleton, Ian R, Jackson, Rod T, Kengne, Andre Pascal, Khang, Young-Ho, Laxmaiah, Avula, Liu, Jing, Malekzadeh, Reza, Neuhauser, Hannelore K, Sorić, Maroje, Starc, Gregor, Sundström, Johan, Woodward, Mark, Ezzati, Majid, Abarca-Gómez, Leandra, Abdeen, Ziad A, Abu-Rmeileh, Niveen M, Acosta-Cazares, Benjamin, Adams, Robert J, Aekplakorn, Wichai, Afsana, Kaosar, Aguilar-Salinas, Carlos A, Agyemang, Charle, Ahmad, Noor Ani, Ahmadvand, Alireza, Ahrens, Wolfgang, Ajlouni, Kamel, Akhtaeva, Nazgul, Al-Raddadi, Rajaa, Ali, Mohamed M, Ali, Osman, Alkerwi, Ala'a, Aly, Eman, Amarapurkar, Deepak N, Amouyel, Philippe, Amuzu, Antoinette, Andersen, Lars Bo, Anderssen, Sigmund A, Ängquist, Lars H, Anjana, Ranjit Mohan, Ansong, Daniel, Aounallah-Skhiri, Hajer, Araújo, Joana, Ariansen, Inger, Aris, Tahir, Arlappa, Nimmathota, Arveiler, Dominique, Aryal, Krishna K, Aspelund, Thor, Assah, Felix K, Assunção, Maria Cecília F, Avdicová, Mária, Azevedo, Ana, Azizi, Fereidoun, Babu, Bontha V, Bahijri, Suhad, Balakrishna, Nagalla, Bamoshmoosh, Mohamed, Banach, Maciej, Bandosz, Piotr, Banegas, José R, Barbagallo, Carlo M, Barceló, Alberto, Barkat, Amina, Barros, Aluisio J D, Barros, Mauro V, Bata, Iqbal, Batieha, Anwar M, Batyrbek, Assembekov, Baur, Louise A, Beaglehole, Robert, Romdhane, Habiba Ben, Benet, Mikhail, Benson, Lowell S, Bernabe-Ortiz, Antonio, Bernotiene, Gailute, Bettiol, Heloisa, Bhagyalaxmi, Aroor, Bharadwaj, Sumit, Bhargava, Santosh K, Bi, Yufang, Bikbov, Mukharram, Bista, Bihungum, Bjerregaard, Peter, Bjertness, Espen, Bjertness, Marius B, Björkelund, Cecilia, Blokstra, Anneke, Bo, Simona, Bobak, Martin, Boeing, Heiner, Boggia, Jose G, Boissonnet, Carlos P, Bongard, Vanina, Borchini, Rossana, Bovet, Pascal, Braeckman, Lutgart, Brajkovich, Imperia, Branca, Francesco, Breckenkamp, Juergen, Brenner, Hermann, Brewster, Lizzy M, Bruno, Graziella, Bueno-de-Mesquita, H B(as), Bugge, Anna, Burns, Con, Bursztyn, Michael, de León, Antonio Cabrera, Cacciottolo, Joseph, Cai, Hui, Cameron, Christine, Can, Günay, Cândido, Ana Paula C, Capuano, Vincenzo, Cardoso, Viviane C, Carlsson, Axel C, Carvalho, Maria J, Casanueva, Felipe F, Casas, Juan-Pablo, Caserta, Carmelo A, Chamukuttan, Snehalatha, Chan, Angelique W, Chan, Queenie, Chaturvedi, Himanshu K, Chaturvedi, Nishi, Chen, Chien-Jen, Chen, Fangfang, Chen, Huashuai, Chen, Shuohua, Cheng, Ching-Yu, Dekkaki, Imane Cherkaoui, Chetrit, Angela, Chiolero, Arnaud, Chiou, Shu-Ti, Chirita-Emandi, Adela, Chirlaque, María-Dolore, Cho, Belong, Cho, Yumi, Christofaro, Diego G, Chudek, Jerzy, Cifkova, Renata, Cinteza, Eliza, Claessens, Frank, Clays, El, Concin, Han, Cooper, Cyru, Cooper, Rachel, Coppinger, Tara C, Costanzo, Simona, Cottel, Dominique, Cowell, Chri, Craig, Cora L, Crujeiras, Ana B, Cruz, Juan J, D'Arrigo, Graziella, d'Orsi, Eleonora, Dallongeville, Jean, Damasceno, Albertino, Dankner, Rachel, Dantoft, Thomas M, Dauchet, Luc, Davletov, Kairat, De Backer, Guy, De Bacquer, Dirk, de Gaetano, Giovanni, De Henauw, Stefaan, de Oliveira, Paula Duarte, De Smedt, Delphine, Deepa, Mohan, Dehghan, Abba, Delisle, Hélène, Deschamps, Valérie, Dhana, Klodian, Di Castelnuovo, Augusto F, Dias-da-Costa, Juvenal Soare, Diaz, Alejandro, Dickerson, Ty T, Do, Ha T P, Donfrancesco, Chiara, Donoso, Silvana P, Döring, Angela, Dorobantu, Maria, Doua, Kouamelan, Drygas, Wojciech, Dulskiene, Virginija, Džakula, Aleksandar, Dzerve, Vilni, Dziankowska-Zaborszczyk, Elzbieta, Eggertsen, Robert, Ekelund, Ulf, El Ati, Jalila, Elliott, Paul, Elosua, Roberto, Erasmus, Rajiv T, Erem, Cihangir, Eriksen, Louise, Eriksson, Johan G, Escobedo-de la Peña, Jorge, Evans, Alun, Faeh, David, Fall, Caroline H, Farzadfar, Farshad, Felix-Redondo, Francisco J, Ferguson, Trevor S, Fernandes, Romulo A, Fernández-Bergés, Daniel, Ferrante, Daniel, Ferrari, Marika, Ferreccio, Catterina, Ferrieres, Jean, Finn, Joseph D, Fischer, Krista, Föger, Bernhard, Foo, Leng Huat, Forslund, Ann-Sofie, Forsner, Maria, Fouad, Heba M, Francis, Damian K, do Carmo Franco, Maria, Franco, Oscar H, Frontera, Guillermo, Fuchs, Flavio D, Fuchs, Sandra C, Fujita, Yuki, Furusawa, Takuro, Gaciong, Zbigniew, Galvano, Fabio, Garcia-de-la-Hera, Manoli, Gareta, Dickman, Garnett, Sarah P, Gaspoz, Jean-Michel, Gasull, Magda, Gates, Louise, Geleijnse, Johanna M, Ghasemian, Anoosheh, Ghimire, Anup, Giampaoli, Simona, Gianfagna, Francesco, Gill, Tiffany K, Giovannelli, Jonathan, Goldsmith, Rebecca A, Gonçalves, Helen, Gonzalez-Gross, Marcela, González-Rivas, Juan P, Gorbea, Mariano Bonet, Gottrand, Frederic, Graff-Iversen, Sidsel, Grafnetter, Dušan, Grajda, Aneta, Grammatikopoulou, Maria G, Gregor, Ronald D, Grodzicki, Tomasz, Grøntved, Ander, Grosso, Giuseppe, Gruden, Gabriella, Grujic, Vera, Gu, Dongfeng, Guan, Ong Peng, Gudmundsson, Elias F, Gudnason, Vilmundur, Guerrero, Ramiro, Guessous, Idri, Guimaraes, Andre L, Gulliford, Martin C, Gunnlaugsdottir, Johanna, Gunter, Marc, Gupta, Prakash C, Gupta, Rajeev, Gureje, Oye, Gurzkowska, Beata, Gutierrez, Laura, Gutzwiller, Felix, Hadaegh, Farzad, Halkjær, Jytte, Hardy, Rebecca, Hari Kumar, Rachakulla, Hata, Jun, Hayes, Alison J, He, Jiang, He, Yuna, Elisabeth, Marleen, Henriques, Ana, Cadena, Leticia Hernandez, Herrala, Sauli, Heshmat, Ramin, Hihtaniemi, Ilpo Tapani, Ho, Sai Yin, Ho, Suzanne C, Hobbs, Michael, Hofman, Albert, Dinc, Gonul Horasan, Horimoto, Andrea R V R, Hormiga, Claudia M, Horta, Bernardo L, Houti, Leila, Howitt, Christina, Htay, Thein Thein, Htet, Aung Soe, Than Htike, Maung Maung, Hu, Yonghua, Huerta, José María, Huisman, Martijn, Husseini, Abdullatif S, Huybrechts, Inge, Hwalla, Nahla, Iacoviello, Licia, Iannone, Anna G, Ibrahim, Mohsen M, Wong, Norazizah Ibrahim, Ikeda, Nayu, Ikram, M Arfan, Irazola, Vilma E, Islam, Muhammad, al-Safi Ismail, Aziz, Ivkovic, Vanja, Iwasaki, Masanori, Jacobs, Jeremy M, Jaddou, Hashem, Jafar, Tazeen, Jamrozik, Konrad, Janszky, Imre, Jasienska, Grazyna, Jelaković, Ana, Jelaković, Bojan, Jennings, Garry, Jeong, Seung-lyeal, Jiang, Chao Qiang, Joffres, Michel, Johansson, Mattia, Jokelainen, Jari J, Jonas, Jost B, Jørgensen, Torben, Joshi, Pradeep, Jóźwiak, Jacek, Juolevi, Anne, Jurak, Gregor, Jureša, Vesna, Kaaks, Rudolf, Kafatos, Anthony, Kajantie, Eero O, Kalter-Leibovici, Ofra, Kamaruddin, Nor Azmi, Karki, Khem B, Kasaeian, Amir, Katz, Joanne, Kauhanen, Jussi, Kaur, Prabhdeep, Kavousi, Maryam, Kazakbaeva, Gyulli, Keil, Ulrich, Boker, Lital Keinan, Keinänen-Kiukaanniemi, Sirkka, Kelishadi, Roya, Kemper, Han C G, Kengne, Andre P, Kerimkulova, Alina, Kersting, Mathilde, Key, Timothy, Khader, Yousef Saleh, Khalili, Davood, Khateeb, Mohammad, Khaw, Kay-Tee, Kiechl-Kohlendorfer, Ursula, Kiechl, Stefan, Killewo, Japhet, Kim, Jeongseon, Kim, Yeon-Yong, Klumbiene, Jurate, Knoflach, Michael, Kolle, Elin, Kolsteren, Patrick, Korrovits, Paul, Koskinen, Seppo, Kouda, Katsuyasu, Kowlessur, Sudhir, Koziel, Slawomir, Kriemler, Susi, Kristensen, Peter Lund, Krokstad, Steinar, Kromhout, Daan, Kruger, Herculina S, Kubinova, Ruzena, Kuciene, Renata, Kuh, Diana, Kujala, Urho M, Kulaga, Zbigniew, Krishna Kumar, R, Kurjata, Pawel, Kusuma, Yadlapalli S, Kuulasmaa, Kari, Kyobutungi, Catherine, Laatikainen, Tiina, Lachat, Carl, Lam, Tai Hing, Landrove, Orlando, Lanska, Vera, Lappas, Georg, Larijani, Bagher, Laugsand, Lars E, Le Nguyen Bao, Khanh, Le, Tuyen D, Leclercq, Catherine, Lee, Jeannette, Lee, Jeonghee, Lehtimäki, Terho, León-Muñoz, Luz M, Levitt, Naomi S, Li, Yanping, Lilly, Christa L, Lim, Wei-Yen, Lima-Costa, M Fernanda, Lin, Hsien-Ho, Lin, Xu, Lind, Lar, Linneberg, Allan, Lissner, Lauren, Litwin, Mieczyslaw, Lorbeer, Roberto, Lotufo, Paulo A, Lozano, José Eugenio, Luksiene, Dalia, Lundqvist, Annamari, Lunet, Nuno, Lytsy, Per, Ma, Guansheng, Ma, Jun, Machado-Coelho, George L L, Machi, Suka, Maggi, Stefania, Magliano, Dianna J, Magriplis, Emmanuella, Majer, Marjeta, Makdisse, Marcia, Malhotra, Rahul, Mallikharjuna Rao, Kodavanti, Malyutina, Sofia, Manios, Yanni, Mann, Jim I, Manzato, Enzo, Margozzini, Paula, Marques-Vidal, Pedro, Marques, Larissa Pruner, Marrugat, Jaume, Martorell, Reynaldo, Mathiesen, Ellisiv B, Matijasevich, Alicia, Matsha, Tandi E, Mbanya, Jean Claude N, Mc Donald Posso, Anselmo J, McFarlane, Shelly R, McGarvey, Stephen T, McLachlan, Stela, McLean, Rachael M, McLean, Scott B, McNulty, Breige A, Mediene-Benchekor, Sounnia, Medzioniene, Jurate, Meirhaeghe, Aline, Meisinger, Christa, Menezes, Ana Maria B, Menon, Geetha R, Meshram, Indrapal I, Metspalu, Andre, Meyer, Haakon E, Mi, Jie, Mikkel, Kairit, Miller, Jody C, Minderico, Cláudia S, Francisco, Juan, Miranda, J Jaime, Mirrakhimov, Erkin, Mišigoj-Durakovic, Marjeta, Modesti, Pietro A, Mohamed, Mostafa K, Mohammad, Kazem, Mohammadifard, Noushin, Mohan, Viswanathan, Mohanna, Salim, Mohd Yusoff, Muhammad Fadhli, Møllehave, Line T, Møller, Niels C, Molnár, Déne, Momenan, Amirabba, Mondo, Charles K, Monyeki, Kotsedi Daniel K, Moon, Jin Soo, Moreira, Leila B, Morejon, Alain, Moreno, Luis A, Morgan, Karen, Moschonis, George, Mossakowska, Malgorzata, Mostafa, Aya, Mota, Jorge, Esmaeel Motlagh, Mohammad, Motta, Jorge, Msyamboza, Kelias P, Mu, Thet Thet, Muiesan, Maria L, Müller-Nurasyid, Martina, Murphy, Neil, Mursu, Jaakko, Musil, Vera, Nabipour, Iraj, Nagel, Gabriele, Naidu, Balkish M, Nakamura, Harunobu, Námešná, Jana, Nang, Ei Ei K, Nangia, Vinay B, Narake, Sameer, Nauck, Matthia, Navarrete-Muñoz, Eva Maria, Ndiaye, Ndeye Coumba, Neal, William A, Nenko, Ilona, Neovius, Martin, Nervi, Flavio, Nguyen, Chung T, Nguyen, Nguyen D, Nguyen, Quang Ngoc, Nguyen, Quang V, Nieto-Martínez, Ramfis E, Niiranen, Teemu J, Ning, Guang, Ninomiya, Toshiharu, Nishtar, Sania, Noale, Marianna, Noboa, Oscar A, Noorbala, Ahmad Ali, Norat, Teresa, Noto, Davide, Al Nsour, Mohannad, O'Reilly, Dermot, Oda, Eiji, Oehlers, Glenn, Oh, Kyungwon, Ohara, Kumiko, Olinto, Maria Teresa A, Oliveira, Isabel O, Omar, Mohd Azahadi, Onat, Altan, Ong, Sok King, Ono, Lariane M, Ordunez, Pedro, Ornelas, Rui, Osmond, Clive, Ostojic, Sergej M, Ostovar, Afshin, Otero, Johanna A, Overvad, Kim, Owusu-Dabo, Elli, Paccaud, Fred Michel, Padez, Cristina, Pahomova, Elena, Pajak, Andrzej, Palli, Domenico, Palmieri, Luigi, Pan, Wen-Harn, Panda-Jonas, Songhomitra, Panza, Francesco, Papandreou, Dimitrio, Park, Soon-Woo, Parnell, Winsome R, Parsaeian, Mahboubeh, Patel, Nikhil D, Pecin, Ivan, Pednekar, Mangesh S, Peer, Nasheeta, Peeters, Petra H, Peixoto, Sergio Viana, Peltonen, Markku, Pereira, Alexandre C, Peters, Annette, Petersmann, Astrid, Petkeviciene, Janina, Pham, Son Thai, Pigeot, Iri, Pikhart, Hynek, Pilav, Aida, Pilotto, Lorenza, Pitakaka, Freda, Piwonska, Aleksandra, Plans-Rubió, Pedro, Polašek, Ozren, Porta, Miquel, Portegies, Marileen L P, Pourshams, Akram, Poustchi, Hossein, Pradeepa, Rajendra, Prashant, Mathur, Price, Jacqueline F, Puder, Jardena J, Puiu, Maria, Punab, Margu, Qasrawi, Radwan F, Qorbani, Mostafa, Bao, Tran Quoc, Radic, Ivana, Radisauskas, Ricarda, Rahman, Mahfuzar, Raitakari, Olli, Raj, Manu, Ramachandra Rao, Sudha, Ramachandran, Ambady, Ramos, Elisabete, Rampal, Lekhraj, Rampal, Sanjay, Rangel Reina, Daniel A, Redon, Josep, Reganit, Paul Ferdinand M, Ribeiro, Robespierre, Riboli, Elio, Rigo, Fernando, Rinke de Wit, Tobias F, Ritti-Dias, Raphael M, Robinson, Sian M, Robitaille, Cynthia, Rodríguez-Artalejo, Fernando, del Cristo Rodriguez-Perez, María, Rodríguez-Villamizar, Laura A, Rojas-Martinez, Rosalba, Romaguera, Dora, Ronkainen, Kimmo, Rosengren, Annika, Roy, Joel G R, Rubinstein, Adolfo, Sandra Ruiz-Betancourt, Blanca, Rutkowski, Marcin, Sabanayagam, Charumathi, Sachdev, Harshpal S, Saidi, Olfa, Sakarya, Sibel, Salanave, Benoit, Salazar Martinez, Eduardo, Salmerón, Diego, Salomaa, Veikko, Salonen, Jukka T, Salvetti, Massimo, Sánchez-Abanto, Jose, Sans, Susana, Santos, Diana A, Santos, Ina S, Nunes dos Santos, Renata, Santos, Rute, Saramies, Jouko L, Sardinha, Luis B, Sarganas, Giselle, Sarrafzadegan, Nizal, Saum, Kai-Uwe, Savva, Savva, Scazufca, Marcia, Schargrodsky, Herman, Schipf, Sabine, Schmidt, Carsten O, Schöttker, Ben, Schultsz, Constance, Schutte, Aletta E, Sein, Aye Aye, Sen, Abhijit, Senbanjo, Idowu O, Sepanlou, Sadaf G, Sharma, Sanjib K, Shaw, Jonathan E, Shibuya, Kenji, Shin, Dong Wook, Shin, Youchan, Si-Ramlee, Khairil, Siantar, Rosalynn, Sibai, Abla M, Santos Silva, Diego Augusto, Simon, Mary, Simons, Judith, Simons, Leon A, Sjöström, Michael, Skovbjerg, Sine, Slowikowska-Hilczer, Jolanta, Slusarczyk, Przemyslaw, Smeeth, Liam, Smith, Margaret C, Snijder, Marieke B, So, Hung-Kwan, Sobngwi, Eugène, Söderberg, Stefan, Solfrizzi, Vincenzo, Sonestedt, Emily, Song, Yi, Sørensen, Thorkild I A, Soric, Maroje, Jérome, Charles Sossa, Soumare, Aicha, Staessen, Jan A, Stathopoulou, Maria G, Stavreski, Bill, Steene-Johannessen, Jostein, Stehle, Peter, Stein, Aryeh D, Stergiou, George S, Stessman, Jochanan, Stieber, Jutta, Stöckl, Dori, Stocks, Tanja, Stokwiszewski, Jakub, Stronks, Karien, Strufaldi, Maria Wany, Sun, Chien-An, Sung, Yn-Tz, Suriyawongpaisal, Paibul, Sy, Rody G, Shyong Tai, E, Tammesoo, Mari-Lii, Tamosiunas, Abdona, Tan, Eng Joo, Tang, Xun, Tanser, Frank, Tao, Yong, Tarawneh, Mohammed Rasoul, Tarqui-Mamani, Carolina B, Tautu, Oana-Florentina, Taylor, Anne, Theobald, Holger, Theodoridis, Xenophon, Thijs, Lutgarde, Thuesen, Betina H, Tjonneland, Anne, Tolonen, Hanna K, Tolstrup, Janne S, Topbas, Murat, Topór-Madry, Roman, Tormo, María José, Torrent, Matie, Traissac, Pierre, Trichopoulos, Dimitrio, Trichopoulou, Antonia, Trinh, Oanh T H, Trivedi, Atul, Tshepo, Lechaba, Tulloch-Reid, Marshall K, Tullu, Fikru, Tuomainen, Tomi-Pekka, Tuomilehto, Jaakko, Turley, Maria L, Tynelius, Per, Tzourio, Christophe, Ueda, Peter, Ugel, Eunice E, Ulmer, Hanno, Uusitalo, Hannu M T, Valdivia, Gonzalo, Valvi, Damaskini, van der Schouw, Yvonne T, Van Herck, Koen, Van Minh, Hoang, van Rossem, Lenie, Van Schoor, Natasja M, van Valkengoed, Irene G M, Vanderschueren, Dirk, Vanuzzo, Diego, Vatten, Lar, Vega, Toma, Velasquez-Melendez, Gustavo, Veronesi, Giovanni, Monique Verschuren, W M, Verstraeten, Roosmarijn, Victora, Cesar G, Viet, Lucie, Viikari-Juntura, Eira, Vineis, Paolo, Vioque, Jesu, Virtanen, Jyrki K, Visvikis-Siest, Sophie, Viswanathan, Bharathi, Vlasoff, Tiina, Vollenweider, Peter, Voutilainen, Sari, Wade, Alisha N, Wagner, Aline, Walton, Janette, Wan Bebakar, Wan Mohamad, Wan Mohamud, Wan Nazaimoon, Wanderley, Rildo S, Wang, Ming-Dong, Wang, Qian, Wang, Ya Xing, Wang, Ying-Wei, Wannamethee, S Goya, Wareham, Nichola, Wedderkopp, Niel, Weerasekera, Deepa, Whincup, Peter H, Widhalm, Kurt, Widyahening, Indah S, Wiecek, Andrzej, Wijga, Alet H, Wilks, Rainford J, Willeit, Johann, Willeit, Peter, Williams, Emmanuel A, Wilsgaard, Tom, Wojtyniak, Bogdan, Wong-McClure, Roy A, Wong, Justin Y Y, Wong, Tien Yin, Woo, Jean, Giwercman Wu, Aleksander, Wu, Frederick C, Wu, Shouling, Xu, Haiquan, Yan, Weili, Yang, Xiaoguang, Ye, Xingwang, Yiallouros, Panayiotis K, Yoshihara, Akihiro, Younger-Coleman, Novie O, Yusoff, Ahmad Faudzi, Zainuddin, Ahmad Ali, Zambon, Sabina, Zampelas, Antoni, Zdrojewski, Tomasz, Zeng, Yi, Zhao, Dong, Zhao, Wenhua, Zheng, Wei, Zheng, Yingfeng, Zhu, Dan, Zhussupov, Baurzhan, Zimmermann, Esther, Cisneros, Julio Zuñiga, The State Key Laboratory of Cell Biology [Shanghai, China] (CAS Center for Excellence in Molecular Cell Science), Shanghai Institute of Biochemistry and Cell Biology [Shanghai, China]-University of Chinese Academy of Sciences [Shanghai, China], Imperial College London, University of Kentucky, Middlesex University, Cleveland Clinic, Universidad Peruana Cayetano Heredia (UPCH), Brandeis University, Mulago Hospital [Kampala, Ouganda], Department of Epidemiology and Public Health, Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), World Health Organisation (WHO), Al-Quds University, Discipline of Medicine, University of South Australia [Adelaide], Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán - National Institute of Medical Science and Nutrition Salvador Zubiran [Mexico], Leibniz Institute for Prevention Research and Epidemiology - BIPS, Leibniz Association, Centre for Industrial Management, Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Epidémiologie des maladies chroniques : impact des interactions gène environnement sur la santé des populations, Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille, Droit et Santé, Institute of Preventive Medicine, Copenhagen University Hospitals, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Dept. Atherosclerose, University of Iceland [Reykjavik], Institute for Biotechnology and Bioengineering (IBB), Technical University of Lisbon, Medical University of Łódź (MUL), Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid (UAM), Faculté de Médecine de Tunis, Université de Tunis El Manar (UTM), Sunder Lal Jain Hospital, Ufa Eye Research Institute [Bashkortostan], National Institute of Public Health, Department of Epidemiology, Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke (DifE), Leibniz Association-Leibniz Association, CHU Toulouse [Toulouse], Institute of Social and Preventive Medicine, Lausanne university hospital, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Department of Medical Sciences [Turin, Italy] (DMS), Università degli studi di Torino = University of Turin (UNITO), ASU - School for Engineering of Matter, Transport and Energy, Arizona State University [Tempe] (ASU), Universidade do Porto = University of Porto, University of Oxford [Oxford], Cancer & Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Consorcio de Investigación Biomédica en Red especializado en Epidemiología y Salud Pública (CIBERESP), Los Centros de Investigación Biomédica en Red (CIBER), 2nd Department of Internal Medicine, Molecular Medicine, Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven)-IRC KULAK, Department of Public Health, State University of Ghent, MRC Lifecourse Epidemiology Unit [Southampton, UK], University of Southampton, Réseau International des Instituts Pasteur (RIIP), Institute of Epidemiology [Neuherberg] (EPI), German Research Center for Environmental Health - Helmholtz Center München (GmbH), Sahlgrenska University Hospital [Gothenburg], Institute of Metabolic Science, MRC, Institut National de Nutrition et de Technologie Alimentaire (INNTA), University of Huddersfield, IMIM-Hospital del Mar, Generalitat de Catalunya, Medstar Research Institute, Queen's University [Belfast] (QUB), Medical Research Council, Applied Sciences, National Research Institute on Food and Nutrition, Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Infectious diseases division, Department of internal medicine, Washington University in Saint Louis (WUSTL), Innsbruck Medical University [Austria] (IMU), Department of Epidemiology [Rotterdam], Erasmus University Medical Center [Rotterdam] (Erasmus MC), Laboratoire d'Etude des Mammifères Marins (LEMM), Océanopolis [Brest], Faculté de Médecine Henri Warembourg - Université de Lille, Institute of Sport Science and Clinical Biomechanics, University of Southern Denmark (SDU), Icelandic Heart Association, Heart Preventive Clinic and Research Institute, Centro Investig Quim Aplicada, Coahuila, Mexico, Centro Investigacion en Quimica Aplicada, Coahuila, Mexico, University of Geneva [Switzerland], Department of Civil Engineering [Hamirpur], National Institute of Technology [Hamirpur], Health Services Research Unit, Danish Cancer Society, Institute of Cancer Epidemiology, London School of Hygiene and Tropical Medicine (LSHTM), University College of London [London] (UCL), The Georges Institute for International Health, The University of Sydney, School of Information Technology, Deakin University Waurn Ponds, Faculté de Médecine, Université Djilali Liabès [Sidi-Bel-Abbès], Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), CIBER de Epidemiología y Salud Pública (CIBERESP), VU University Medical Center [Amsterdam], Universiteit Gent = Ghent University [Belgium] (UGENT), Faculty of Agricultural and Food Science, American University of Beirut [Beyrouth] (AUB), Åbo Akademi University [Turku], Department of Public Health Sciences, Karolinska Institutet [Stockholm], Great Lakes Institute for Environmental Research, University of Windsor [Ca], Universität Heidelberg [Heidelberg], Research Center for Prevention and Health, University of Ljubljana, Division of Cancer Epidemiology, University of Crete School of medicine, School of Public Health and Clinical Nutrition, University of Eastern Finland, Institute of Epidemiology and Social Medicine, Westfälische Wilhelms-Universität Münster = University of Münster (WWU), Research Institute of Child Nutrition Dortmund, Rheinische Friedrich-Wilhelms-Universität Bonn, Cancer Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge [UK] (CAM), Department of Oncology, University of Tampere Medical School, University of Tampere, Wageningen University and Research [Wageningen] (WUR), Centre for Environmental Health, National Institue of Public Health, School of Public Health, The University of Hong Kong (HKU), Tehran University of Medical Sciences, Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione (INRAN), INRAN, National University of Singapore (NUS), Faculty of Medicine and Life Sciences [Tampere], University of Tampere [Finland], Centre Européen de Réalité Virtuelle (CERV), École Nationale d'Ingénieurs de Brest (ENIB), Uppsala Universitet [Uppsala], Department of Public Health and Community Medicine, University of Gothenburg (GU), Institute of Earthquake Science, CEA, Beijing, CEA, Beijing, University of Porto Medical School, Laboratoire de Chimie Physique D'Orsay (LCPO), Université Paris-Sud - Paris 11 (UP11)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Aging Program, National research council, Padua, Italy, Baker IDI Heart and Diabetes Institute, Institute of Internal Medicine, Russian Academy of Medical Sciences, Department of Nutrition and Dietetics, Harokopio University, Emory University [Atlanta, GA], Départment of Biotechnology, Faculty of Science, University of Oran Es-Senia [Oran] | Université d'Oran Es-Senia [Oran], Institut National de la Santé et de la Recherche Médicale (INSERM), University of Tartu, Department of Community, Université Ain Shams-Faculty of Medicine-Environmental and Occupational Medicine, Pécsi Tudemányegyetem, Department of Community, Environmental and Occupational Medicine, Université Ain Shams, Research Centre in Physical Activity, Health and Leisure, Nutrition and Metabolism Section, International Agency for Research on Cancer, Bushehr University of Medical Sciences, Institute of Epidemiology and Medical Biometry [Ulm, Allemagne], Universität Ulm - Ulm University [Ulm, Allemagne], Università degli studi di Palermo - University of Palermo, MRc Environmental Epidemiology Unit, Department of Cardiology and Department of Clinical Epidemiology, Aarhus University Hospital, Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Department of Epidemiology and Population Studies, Jagiellonian University, Uniwersytet Jagielloński w Krakowie = Jagiellonian University (UJ), Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute – ISPO, Social Robotics Laboratory, University of Freiburg, Freiburg im Breisgau, Department of Ophthalmology, Universitätsklinikum Mannheim, Medizinische Fakultät Mannheim der Universität Heidelberg, University of Bari Aldo Moro (UNIBA), Department of Cardiology, Eastbourne General Hospital, Julius Center for Health Sciences and Primary Care, University Medical Center [Utrecht], Laboratoire d'Innovation pour les Technologies des Energies Nouvelles et les nanomatériaux (LITEN), Institut National de L'Energie Solaire (INES), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Centre National de la Recherche Scientifique (CNRS), King‘s College London, Public Health Sciences, University of Edinburgh, Movement Disorders and Tourette Centre, Genetica medicala, Victor Babeş University of Medicine and Pharmacy (UMFT), Andrology Unit, United Laboratories of Tartu University Clinics, Tampere University Hospital, Department of Hygiene and Epidemiology, Dept of Epidemiology and Public Health, Department of Epidemiology and Biostatistics, Imperial College London-School of public health, The University of Hong Kong (HKU)-The University of Hong Kong (HKU), Department of Emergency and Cardiovascular Medicine, Sahlgrenska Academy, Institut de Veille Sanitaire (INVS), Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain, parent, Department of Chronic Disease Prevention, National Institute for Health and Welfare [Helsinki], University of São Paulo (USP), Institut de Recherche pour le Développement (IRD [France-Sud]), Institute for plasma research, Institute for Plasma Research, Department of Biosciences and Nutrition, Department of Reproductive Endocrinology, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC - Academic medical center, Central Hospital and Faculty of medicine and biomedical sciences university, University of Yaoundé [Cameroun], Department of Clinical Sciences, Lund University [Lund]-Lund University Diabetes Centre, School of Computing [Leeds], University of Leeds, Copenhagen University Hospital, Neuroépidémiologie, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Maastricht University [Maastricht], Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire (IGE-PCV), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Applied Food Science, Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, University of Amsterdam, Dept. of Social Medecine, Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University Hospital, Africa Centre for Health and Population Studies, University of KwaZulu-Natal [Durban, Afrique du Sud] (UKZN)-Medical Research Council of South Africa, Center for Family and Community Medicine, Department of Neurobiology, Care Sciences and Society, Department of Cardiovascular Sciences [Leuven], Cancer Epidemiology Institute, Department of Epidemiology and Health Promotion (MONICA Data Centre), National Public Health Institute, Nutrition et Alimentation des Populations aux Suds (NutriPass), Université Montpellier 1 (UM1)-Institut de Recherche pour le Développement (IRD)-Université Montpellier 2 - Sciences et Techniques (UM2)-Université de Montpellier (UM)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), Havard School of Public Health, Dept of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School [Athens], University of Kuopio, Tampere University, University Medical Centre Utrecht, Department of Social Medicine, Amsterdam, Center for Metabolic Bone Diseases, Catholic University of Leuven, Norwegian University of Science and Technology [Trondheim] (NTNU), Norwegian University of Science and Technology (NTNU), Universidad Miguel Hernández [Elche] (UMH), Institute of Public Health and Clinical Nutrition [Kuopio, Finland], Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg (UNISTRA), Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Division of Community Health Sciences, St George's University of London, Medizinische Universität Wien = Medical University of Vienna, Medical University of Silesia (SUM), National Institute for Public Health and the Environment [Bilthoven] (RIVM), University of Innsbruck, National Institute of Hygiene Warsaw, Johns Hopkins University School of Medicine [Baltimore], Food Science and Technology, Beijing Forestry University, College of Automation Engineering, Nanjing University of Aeronautics and Astronautics (CAE-NUAA), NUAA, Chinese Center for Disease Control and Prevention, Department of Applied Mathematics, School of Science, Northwestern Polytechnical University, Xi’an, Shaanxi 710072, Siemens Corporate Research, Siemens AG [Munich], Franche-Comté Électronique Mécanique, Thermique et Optique - Sciences et Technologies (UMR 6174) (FEMTO-ST), Université de Technologie de Belfort-Montbeliard (UTBM)-Ecole Nationale Supérieure de Mécanique et des Microtechniques (ENSMM)-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), This work was supported by the Wellcome Trust [101506/Z/13/Z]., NCD Risk Factor Collaboration (NCD-RisC). We thank WHO country and regional offices and the World Heart Federation for support in data identification and access., Universidad Autonoma de Madrid (UAM), University of Turin, Universidade do Porto, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Université Lille 2 - Faculté de Médecine, Westfälische Wilhelms-Universität Münster (WWU), Centre National de la Recherche Scientifique (CNRS)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Centre National de la Recherche Scientifique (CNRS)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), University of KwaZulu-Natal (UKZN)-Medical Research Council of South Africa, Institut de Recherche pour le Développement (IRD)-Université Montpellier 1 (UM1)-Université Montpellier 2 - Sciences et Techniques (UM2)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Université de Montpellier (UM), Université de Technologie de Belfort-Montbeliard (UTBM)-Ecole Nationale Supérieure de Mécanique et des Microtechniques (ENSMM)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre National de la Recherche Scientifique (CNRS), Lund University Diabetes Centre-Lund University [Lund], Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro), Medical University of Silesia, Katowice, Apollo - University of Cambridge Repository, University of Kentucky (UK), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Lausanne University Hospital, University of Oxford, Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Innsbruck Medical University = Medizinische Universität Innsbruck (IMU), Université de Genève = University of Geneva (UNIGE), Deakin University [Waurn Ponds], Universiteit Gent = Ghent University (UGENT), Universität Heidelberg [Heidelberg] = Heidelberg University, Università degli studi di Bari Aldo Moro = University of Bari Aldo Moro (UNIBA), Universidade de São Paulo = University of São Paulo (USP), Lund University [Lund], Laboratoire Chrono-environnement (UMR 6249) (LCE), Leopold Franzens Universität Innsbruck - University of Innsbruck, National Institute of Public Health - National Institute of Hygiene [Poland], Yiallouros, Panayiotis K. [0000-0002-8339-9285], Giampaoli, Simona [0000-0002-6679-1488], Moschonis, George [0000-0003-3009-6675], Papandreou, Dimitrios [0000-0002-4923-484X], Stathopoulou, Maria G. [0000-0003-4376-2083], Stergiou, George S. [0000-0002-6132-0038], Trichopoulou, Antonia [0000-0002-7204-6396], Valvi, Damaskini [0000-0003-4633-229X], Chen, Z, Woodward, M, Key, T, and Smith, M
- Subjects
systolic blood pressure ,Settore MED/09 - Medicina Interna ,blood pressure measurement ,HEALTH EXAMINATION SURVEYS ,Blood Pressure ,Hypertension ,Population Health ,Global Health ,Non-communicable Disease ,Epidemiology ,[SDV]Life Sciences [q-bio] ,global health ,South Asia ,purl.org/pe-repo/ocde/ford#3.03.09 [https] ,kohonnut verenpaine ,Medicine and Health Sciences ,middle income country ,measurement method ,skin and connective tissue diseases ,VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771 ,Public, Environmental & Occupational Health ,adult ,Population health ,public health ,blood pressure regulation ,Public Health, Global Health, Social Medicine and Epidemiology ,Non-communicable disease ,kansainvälinen vertailu ,health survey ,aged ,female ,priority journal ,Blood pressure ,mean arterial pressure ,GLOBAL TRENDS ,SODIUM-INTAKE ,Life Sciences & Biomedicine ,survey design ,hypertension ,prevalence ,Global health ,UNITED-STATES ,URBAN COMMUNITIES ,Article ,SECULAR TRENDS ,Middle East ,Central Asia ,male ,disease prevalence ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,kansanterveys ,blood ,SYSTEMATIC ANALYSIS ,human ,verenpainetauti ,non-communicable disease ,Science & Technology ,Pacific Ocean ,high income country ,diastolic blood pressure ,Pacific Rim ,Blood Pressure - Epidemiology - Population ,North Africa ,major clinical study ,HYPERTENSION PREVALENCE ,verenpaine ,Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi ,ARTERIAL-HYPERTENSION ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,POTASSIUM INTAKE ,sense organs ,trend analysis ,trend study ,population research ,population health ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,low income country - Abstract
Background: Change in the prevalence of raised blood pressure could be due to both shifts in the entire distribution of blood pressure (representing the combined effects of public health interventions and secular trends) and changes in its high-blood-pressure tail (representing successful clinical interventions to control blood pressure in the hypertensive population). Our aim was to quantify the contributions of these two phenomena to the worldwide trends in the prevalence of raised blood pressure. Methods: We pooled 1018 population-based studies with blood pressure measurements on 88.6 million participants from 1985 to 2016. We first calculated mean systolic blood pressure (SBP), mean diastolic blood pressure (DBP) and prevalence of raised blood pressure by sex and 10-year age group from 20-29 years to 70-79 years in each study, taking into account complex survey design and survey sample weights, where relevant. We used a linear mixed effect model to quantify the association between (probit-transformed) prevalence of raised blood pressure and age-group-and sex-specific mean blood pressure. We calculated the contributions of change in mean SBP and DBP, and of change in the prevalence-mean association, to the change in prevalence of raised blood pressure. Results: In 2005-16, at the same level of population mean SBP and DBP, men and women in South Asia and in Central Asia, the Middle East and North Africa would have the highest prevalence of raised blood pressure, and men and women in the high-income Asia Pacific and high-income Western regions would have the lowest. In most region-sex-age groups where the prevalence of raised blood pressure declined, one half or more of the decline was due to the decline in mean blood pressure. Where prevalence of raised blood pressure has increased, the change was entirely driven by increasing mean blood pressure, offset partly by the change in the prevalence-mean association. Conclusions: Change in mean blood pressure is the main driver of the worldwide change in the prevalence of raised blood pressure, but change in the high-blood-pressure tail of the distribution has also contributed to the change in prevalence, especially in older age groups., This work was supported by the Wellcome Trust [101506/Z/13/Z].
- Published
- 2018
- Full Text
- View/download PDF
108. Repositioning of the global epicentre of non- optimal cholesterol
- Author
-
Taddei, Cristina, Dika, Živka, Jelaković, Ana, Jelaković, Bojan, and Ezzati, Majid
- Subjects
lipids (amino acids, peptides, and proteins) ,cholesterol, HDL cholesterol, lipid-related risk, epidemiology - Abstract
High blood cholesterol is typically considered a feature of wealthy western countries. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high- density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1, 127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk— changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non- HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non- optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.
- Published
- 2020
109. RETROPERITONEALNA FIBROZA: RIJEDAK OBLIK PARANEOPLASTIČNOG SINDROMA U SKLOPU KARCINOMA PLUĆA
- Author
-
Škoro, Matea, Banić, Marko, Baričević, Denis, Boras, Zagorka, Jakopović, Marko, Jelaković, Bojan, Kovačić, Helena, Laganović, Mario, Trkeš, Vesna, and Vukić Dugac, Andrea
- Subjects
paraneoplastički sindrom, karcinom pluća, retroperitonealna fibroza - Abstract
UVOD Retroperitonealna fibroza (RPF) rijetko je stanje nespecifične kliničke prezentacije koje definiramo kao fibrozu retroperitonealnog tkiva koje okružuje infrarenalni dio abdominalne aorte. Iako u 70% idiopatske geneze (IgG4-povezana i IgG4- nepovezana RFP), danas su poznati brojni sekundarni uzroci RFP od kojih su najčešći lijekovi, maligne bolesti, infekcije, radioterapija te abdominalni i retroperitonealni operativni zahvati, retroperitonealna trauma i krvarenje, amiloidoza itd. Najčešće maligne bolesti koje se povezuju s nastankom sekundarne RFP su karcinoid, Hodgkin i nonHodgkin limfomi, sarkomi, karcinomi kolona, prostate i dojke. Iako rijetko, zabilježena je i pojava RPF kao posljedice karcinoma pluća, a upravo će dijagnostički i terapijski put jednog takvog bolesnika biti prikazan u daljnjem tekstu. PRIKAZ SLUČAJA 45- godišnji V.A., dugogodišnji pušač sa poznatom prirođenom srčanom greškom u redovitim kontrolama, početkom 2020. godine liječen je u vanjskoj ustanovi zbog otekline desnog testisa i bolova u lumbalnoj kralježnici, bez smetnji mokrenja i općih simptoma. MSCT-urografija pokaže desnostranu hidronefrozu uz infrarenalne retroperitonealne promjene otvorene etiologije koje prvenstveno odgovaraju početnoj RFP. MSCT toraksa i abdomena u ožujku 2020. osim promjena retroperitoneuma i obostrane dilatacije kanalnog sustava bubrega II.stupnja, pokaže i tri nodozne lezije lijevog hilusa pluća koje se inicijalno okarakteriziraju kao sekundarizmi, infiltraciju repa gušterače, umnožene limfne čvorove zdjelice te promijenjenu strukturu L2 kralješka. Učini se biopsija retroperitoneuma kojom se potvrdi dijagnoza RFP, bez znakova limfoproliferativne bolesti niti IgG4-vezane bolesti. Početkom travnja dolazi do naglog pogoršanja kliničke slike bolesnika posljedično postrenalnoj azotemiji zbog čega se podvrgne hitnoj hemodijalizi te postavljanju obostranih JJ- proteza. Bolesnik je 6.4.2020. premješten u KBC Zagreb gdje se, unatoč primjerenom položaju JJ-proteza, prati hidronefroza desnog bubrega te se obostrano postave perkutane nefrostome. Zbog povišenih parametara upale i hipotireoze, započne se s empirijskom antibiotskom terapijom i supstitucijskom terapijom levofloksacinom. PET/CT potvrdi patološko nakupljanje analoga glukoze u ranije suspektnim sijelima retroperitoneuma, hilusa slezene i lijevog hilusa pluća, a uoči se i patološka metabolička aktivnost u desnim paratrahealnim i hilarnim limfnim čvorovima. Nakon dijagnostički neuspješne bronhoskopije i biopsije pluća, adekvatan materijal za patohistološku analizu konačno se dobije transbronhalnom aspiracijom iglom pod kontrolom EBUS- a te se 26.5.2020. postavi dijagnoza planocelularnog karcinoma pluća, PD-L1 90%. Obzirom na patohistološki tip i stadij bolesti (IV), ECOG 0, započne se terapija pembrolizumabom, a nakon 3. ciklusa terapije, prati se značajna radiološka regresija veličine tumorskog procesa.
- Published
- 2020
110. Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: Consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient
- Author
-
Kotsis, V, Jordan, J, Stabouli, S, Antza, C, Micic, D, Jelaković, B, Schlaich, M, Nilsson, P, Kreutz, R, Mancia, G, Tsioufis, K, Grassi, G, Kotsis, Vasilios, Jordan, Jens, Stabouli, Stella, Antza, Christina, Micic, Dragan, Jelaković, Bojan, Schlaich, Markus P, Nilsson, Peter M, Kreutz, Reinhold, Mancia, Giuseppe, Tsioufis, Kostas, Grassi, Guido, Kotsis, V, Jordan, J, Stabouli, S, Antza, C, Micic, D, Jelaković, B, Schlaich, M, Nilsson, P, Kreutz, R, Mancia, G, Tsioufis, K, Grassi, G, Kotsis, Vasilios, Jordan, Jens, Stabouli, Stella, Antza, Christina, Micic, Dragan, Jelaković, Bojan, Schlaich, Markus P, Nilsson, Peter M, Kreutz, Reinhold, Mancia, Giuseppe, Tsioufis, Kostas, and Grassi, Guido
- Abstract
The prevalence of type 2 diabetes (T2D) has increased over the past few decades. T2D has a strong genetic propensity that becomes overt when a patient is exposed to a typical Western lifestyle, gain weight and becomes obese, whereas weight loss protects from the development of T2D. Except of lifestyle modifications, the choice of the appropriate treatment is essential in the management of patients with T2D and appears critical for the obese population with T2D. The new pharmacological approach for the treatment of T2D, sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists, seems to be effective not only in the management of T2D but also for weight loss, reduction of blood pressure and improvement of nonalcoholic fatty liver disease. Sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 analogues reduced cardiovascular risk, prevented cardiovascular disease and mortality, thereby playing an important role in the treatment of obese patients with hypertension and T2D.
- Published
- 2020
111. Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure.
- Author
-
Karanović, Sandra, Ardin, Maude, Tang, Zuojian, Tomić, Karla, Villar, Stephanie, Renard, Claire, Venturini, Elisa, Lorch, Adam H., Lee, Daniel S., Stipančić, Želimir, Slade, Neda, Vuković Brinar, Ivana, Dittrich, Damir, Karlović, Krešimir, Borovečki, Fran, Dickman, Kathleen G., Olivier, Magali, Grollman, Arthur P., Jelaković, Bojan, and Zavadil, Jiri
- Subjects
BLADDER cancer ,ARISTOLOCHIC acid ,MESSENGER RNA ,DNA ,RNA ,TRANSITIONAL cell carcinoma ,INTEGRATIVE medicine ,IMMUNOTHERAPY - Abstract
Recurrent upper tract urothelial carcinomas (UTUCs) arise in the context of nephropathy linked to exposure to the herbal carcinogen aristolochic acid (AA). Here we delineated the molecular programs underlying UTUC tumorigenesis in patients from endemic aristolochic acid nephropathy (AAN) regions in Southern Europe. We applied an integrative multiomics analysis of UTUCs, corresponding unaffected tissues and of patient urines. Quantitative microRNA (miRNA) and messenger ribonucleic acid (mRNA) expression profiling, immunohistochemical analysis by tissue microarrays and exome and transcriptome sequencing were performed in UTUC and nontumor tissues. Urinary miRNAs of cases undergoing surgery were profiled before and after tumor resection. Ribonucleic acid (RNA) and protein levels were analyzed using appropriate statistical tests and trend assessment. Dedicated bioinformatic tools were used for analysis of pathways, mutational signatures and result visualization. The results delineate UTUC‐specific miRNA:mRNA networks comprising 89 miRNAs associated with 1,862 target mRNAs, involving deregulation of cell cycle, deoxyribonucleic acid (DNA) damage response, DNA repair, bladder cancer, oncogenes, tumor suppressors, chromatin structure regulators and developmental signaling pathways. Key UTUC‐specific transcripts were confirmed at the protein level. Exome and transcriptome sequencing of UTUCs revealed AA‐specific mutational signature SBS22, with 68% to 76% AA‐specific, deleterious mutations propagated at the transcript level, a possible basis for neoantigen formation and immunotherapy targeting. We next identified a signature of UTUC‐specific miRNAs consistently more abundant in the patients' urine prior to tumor resection, thereby defining biomarkers of tumor presence. The complex gene regulation programs of AAN‐associated UTUC tumors involve regulatory miRNAs prospectively applicable to noninvasive urine‐based screening of AAN patients for cancer presence and recurrence. What's new? Ingestion of aristolochic acid (AA) via contaminated wheat‐containing food products is a major cause of endemic neuropathy and urologic carcinogenesis in southeastern Europe. Here, using integrated multi‐omics analysis, the authors identified molecular programs underlying upper tract urothelial tumors (UTUC) in patients in Southern Europe with past carcinogenic AA exposure. Analyses reveal associations between 89 miRNAs and 1,862 target mRNAs, with confirmation of UTUC‐specific transcripts at protein level. AA‐specific mutations in UTUC and deleterious mutations were uncovered at both gene and transcript levels. The findings suggest that tumors in the urinary tract can be monitored by urine miRNA signature. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
112. UDIO BOLESNIKA NA LISTI ČEKANJA ZA TRANSPLANTACIJU BUBREGA I PRIDRUŽENE BOLESTI – IMA LI MJESTA ZA POBOLJŠANJE?
- Author
-
Bašić-Jukić, Nikolina, Vujičić, Božidar, Radić, Josipa, Belavić, Žarko, Kudumija, Boris, Katalinić, Lea, Jerin, Lems, Stipanić, Sanja, Jelaković, Bojan, Ljutić, Draga, and Rački, Sanjin
- Subjects
lista čekanja ,BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences ,transpantacija bubrega ,BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti - Abstract
Transplantacija bubrega je najbolja metoda nadomještanja bubrežne funkcije za sve bolesnike sa završnim stadijem kronične bubrežne bolesti koji nemaju kontraindikacije za operativni zahvat i za primjenu imunosupresijske terapije (1). Republika Hrvatska je jedna od vodećih zemalja svijeta po broju darovatelja organa, ali i po broju transplantacija bubrega na milijun stanovnika. To je rezultat dugogodišnjih napora svih subjekata uključenih u proces donacije i transplantacije organa uz snažnu podršku medija, crkve i opće populacije.
- Published
- 2019
113. Epidemiology of Hypertension and salt intake in Croatia (EH-UH2)
- Author
-
Marinović Glavić, Mihaela, Vasiljev, Vanja, Bilajac, Lovorka, Rukavina, Tomislav, Jelaković, Bojan, Bilajac, Lovorka, and Vasiljev, Vanja
- Subjects
hypertension, salt intake, cardiovascular disease - Abstract
biti će objavljen naknadno
- Published
- 2019
114. The Position of the Croatian Society of Hypertension on the Observed Increase in Risk of Non-melanoma Skin Cancer Associated with Hydrochlorothiazide Treatment
- Author
-
Jelaković, Bojan, Drenjančević, Ines, Laganović, Mario, Pećin, Ivan, Jelaković, Ana, Baretić, Maja, Dika, Živka, Ivanuša, Mario, Herceg-Čavrak, Vesna, Josipović, Josipa, Kralj, Verica, Leko, Ninoslav, Likić, Robert, Lovrić Benčić, Martina, Orlić, Lidija, Pavlović, Draško, Počanić, Darko, Prkačin, Ingrid, Stevanović, Ranko, Tiljak, Hrvoje, and Željković Vrkić, Tajana
- Subjects
Hydrochlorothiazide, Non-melanoma Skin Cancer, position paper - Abstract
Upravni odbor Hrvatskoga društva za hipertenziju na svojoj elektroničkoj sjednici održanoj 12. prosinca 2018. raspravljao je o opaženom povećanom riziku za nastanak nemelanomskih karcinoma kože povezanom s liječenjem hidroklorotiazidom i pripremio sljedeće mišljenje. Zaključci 1. Rizik od nemelanomskoga karcinoma kože i usnica veći je u bolesnika liječenih hidroklorotiazidom nego što je u osoba koje nisu liječene ovim lijekom. Rizik se povećava s duljinom trajanja liječenja, tj. s kumulativnom dozom. 2. Mehanizam karcinogenosti hidroklorotiazida temelji se na fotosenzitivnosti. UV zračenje dovodi do disocijacije kloridnoga dijela molekule lijeka, čime se stvara pretpostavka za sintezu slobodnih radikala kisika i posljedično oštećenje molekule DNK. 3. Korist od primjene hidroklorotiazida veća je od rizika. 4. Omjer koristi i rizika napose je veći u starijih i teže bolesnih osoba. 5. Bolesnik mora biti informiran o postojećem riziku. 6. Bolesnik mora biti informiran o postojećoj alternativnoj terapiji koja je na raspolaganju u Hrvatskoj. 7. Svaki liječnik mora u svakoga pojedinog bolesnika procijeniti omjer koristi i rizika te nakon razgovora s bolesnikom odlučiti nastavlja li terapiju hidroklorotiazidom ili se odlučuje za postojeću alternativu. 8. Svim bolesnicima, a napose bolesnicima koji su liječeni hidroklorotiazidom, treba preporučiti uporabu adekvatne fotoprotekcije i redovito provjeravanja pojave ili promjena na koži.
- Published
- 2019
115. INTER-ARM BLOOD PRESSURE DIFFERENCE AND MORTALITY – EPIDEMIOLOGY OF HYPERTENSION IN CROATIA (EHUH STUDY)
- Author
-
Miličić, Borna, Stevanović, Ranko, Knežević, Tamara, Krtalić, Branimir, Željković Vrkić, Tajana, Kos, Jelena, Đapić, Krešmir, Gellineo, Lana, Domislović, Viktor, Ćatić Ćuti, Edina, Jelaković, Ana, Dika, Živka, Capak, Krunoslav, Jelaković, Bojan, Knotek, Mladen, and Laganović, Mario
- Subjects
inter-arm blood pressure, mortality, epidemiology, hypertension, ehuh study - Abstract
doi: 10.1097/01.hjh.0000571032.09151.d9
- Published
- 2019
116. OBESITY AND MORTALITY - RESULTS FROM THE EPIDEMIOLOGY OF HYPERTENSION IN CROATIA (EHUH STUDY) - MORTALITY DATA AFTER 17 YEARS OF FOLLOW- UP
- Author
-
Knezević, Tamara, Stevanović, Ranko, Krtalić, Branimir, Željković Vrkić, Tajana, Kos, Jelena, Pećin, Ivan, Đapić, Krešimir, Domislović, Viktor, Catić Ćuti, Edina, Jelaković, Ana, Dika, Živka, Capak, Krunoslav, Jelaković, Bojan, and Heagerty, Anthony M
- Subjects
obesity, mortality, hypertension, ehuh study, epidemiology - Abstract
doi: 10.1097/01.hjh.0000571812.61906.90
- Published
- 2019
117. Rising rural body-mass index is the main driver of the global obesity epidemic in adults
- Author
-
Bixby, Honor, Bentham, James, Zhou, Bin, Di Cesare, Zhou, Paciorek, Christopher J., Bennett, James E., Taddei, Cristina, Stevens, Gretchen A., Rodriguez-Martinez, Andrea, Carrillo-Larco, Rodrigo M., Khang, Young-Ho, Sorić, Maroje, Dika, Živka, Jureša, Vesna, Majer, Marjeta, Mišigoj- Duraković, Marjeta, Musić Milanović, Sanja, Musil, Vera, Ivković, Vanja, Jelaković, Ana, Jelaković, Bojan, Pećin, Ivan, Zeljković Vrkić, Tajana, and Lang Morović, Maja...Ezzati, Majid
- Subjects
rural ,urban ,BMI - Abstract
Body-mass index (BMI) has increased steadily in most countries in parallel with a rise in the proportion of the population who live in cities1, 2. This has led to a widely reported view that urbanization is one of the most important drivers of the global rise in obesity3, 4, 5, 6. Here we use 2, 009 population-based studies, with measurements of height and weight in more than 112 million adults, to report national, regional and global trends in mean BMI segregated by place of residence (a rural or urban area) from 1985 to 2017. We show that, contrary to the dominant paradigm, more than 55% of the global rise in mean BMI from 1985 to 2017—and more than 80% in some low- and middle-income regions—was due to increases in BMI in rural areas. This large contribution stems from the fact that, with the exception of women in sub-Saharan Africa, BMI is increasing at the same rate or faster in rural areas than in cities in low- and middle- income regions. These trends have in turn resulted in a closing—and in some countries reversal—of the gap in BMI between urban and rural areas in low- and middle-income countries, especially for women. In high-income and industrialized countries, we noted a persistently higher rural BMI, especially for women. There is an urgent need for an integrated approach to rural nutrition that enhances financial and physical access to healthy foods, to avoid replacing the rural undernutrition disadvantage in poor countries with a more general malnutrition disadvantage that entails excessive consumption of low- quality calories.
- Published
- 2019
- Full Text
- View/download PDF
118. Praktične smjernice za dijagnostiku i liječenje arterijske hipertenzije u djece i adolescenata
- Author
-
Herceg-Čavrak, Vesna, Šarić, Dalibor, Kniewald, Hrvoje, Tokić Pivac, Višnja, Ćuk, Martin, Trutin, Ivana, Košuljandić, Đurđica, Arapović, Adela, Balažin, Dejan, Musil, Vera, Jureša, Vesna, Jelaković, Bojan, Benco, Nikolina, and Valent Morić, Bernardica
- Subjects
adolescenti ,arterijski tlak ,djeca ,dijagnostika ,hipertenzija ,liječenje - Abstract
Pedijatrijska hipertenzija postaje sve veći javnozdravstveni problem jer brojna istraživanja upozoravaju na to da su povišene vrijednosti arterijskoga tlaka češće u djece i adolescenata nego li se prije mislilo. Hipertenzija se iz djetinjstva, a osobito adolescencije prosljeđuje u odraslu dob i time povećava rizik za kardiovaskularne bolesti u odrasloj dobi. Stoga su načinjene brojne internacionalne i nacionalne smjernice za dijagnostiku i liječenje pedijatrijske hipertenzije. One su se periodički obnavljale i dopunjavale od prvih preporuka iz 1977. godine sve do posljednjih godina kad su 2016. godine objavljene europske smjernice European Society of Hypertension (ESH) i 2017. godine smjernice American Academy of Pediatrics (AAP). U izradi naših smjernica sudjelovali su pedijatrijski kardiolozi i nefrolozi te liječnici školske medicine, rukovodeći se novim spoznajama koje su na tom polju načinjene posljednjih godina, prilagođene našim mogućnostima i okolnostima. Europske i američke smjernice suglasne su u velikom broju preporuka, ali se u nekim bitnim detaljima kao što je, primjerice klasifikacija hipertenzije, razlikuju. Mi smo se u tome priklonili europskim uputama. Svrha tih smjernica jest da budu praktične i razumljive, s jasnim preporukama kako dijagnosticirati hipertenziju u djece i kako postupati s takvim bolesnicima. Sve važne preporuke nastojali smo sažeti u tablice i izdvojene kartice da bi bile što preglednije i lako dostupne. Namjera nam je bila da te upute budu korisne u svakodnevnom kliničkom radu svim liječnicima koji se bave djecom – pedijatrima, liječnicima školske i obiteljske medicine, ali i pedijatrijskim kardiolozima i nefrolozima. Vjerujemo da će ove smjernice potaknuti liječnike na bolju prevenciju, dijagnostiku i liječenje hipertenzije u djece i adolescenata i time pridonijeti smanjenju kardiovaskularnih bolesti u odrasloj dobi.
- Published
- 2019
119. EPIDEMIOLOGY OF HYPERTENSION IN CROATIA (EHUH STUDY)- MORTALITY DATA AFTER 17 YEARS OF FOLLOW-UP
- Author
-
Stevanović, Ranko, Knezević, Tamara, Krtalič, Branimir, Željković Vrkić, Tajana, Kos, Jelena, Pećin, Ivan, Đapić, Krešimir, Gellineo, Lana, Domislović, Viktor, Čatić Ćuti, Edina, Jelaković, Ana, Dika, Živka, Capak, Krunoslav, Jelaković, Bojan, and Heagerty, Anthony M
- Subjects
ehuh study, epidemiology, hypertension, mortality - Abstract
doi: 10.1097/01.hjh.0000571284.77880.15
- Published
- 2019
120. Risk assessment for cancer development associated with the use of antihypertensives
- Author
-
Levicki, Rea, Benčić, Martina Lovrić, and Jelaković, Bojan
- Subjects
antihipertenzivi ,karcinom ,hidroklorotiazid ,antihypertensives ,carcinoma ,hydrochlorothiazide - Abstract
Brojna su klinička istraživanja ispitivala mogući karcinogeni učinak anihipertenzivnih lijekova. Istraživan je njihov učinak na nastanak karcinoma prostate, kože, dojke, bubrega i pluća. Dokazano je da ukupni rizik od nastanka karcinoma pri uporabi svih antihipertenziva nije povišen. Za pojedine skupine karcinoma dokazano je smanjenje rizika od nastanka maligne bolesti uz uporabu antihipertenzivne terapije. Dobivene su vrijednosti jednake pri dugotrajnoj uporabi lijekova (> 7,5 godina); s duljinom primjene terapije ne dolazi do očekivanog porasta rizika, dok se u nekim istraživanjima vrijednost relativnog rizika s duljinom uporabe antihipertenziva smanjuje. Nijedna skupina antihipertenziva nije bila vezana s povišenim relativnim rizikom od nastanka karcinoma prostate, štoviše, uporaba beta-blokatora i dugogodišnja uporaba alfa-blokatora imala je protektivan učinak. Agencija za lijekove i medicinske proizvode i Europska agencija za lijekove obavještavaju o povišenom riziku od nastanka nemelanomskog raka kože uz uporabu hidroklorotiazida. Hrvatsko društvo za hipertenziju preporučuje razmotriti u kliničkoj praksi omjer koristi i rizika terapije hidroklorotiazidom, adekvatno informirati pacijenta te zajedno s njim donijeti odluku o daljnjoj uporabi hidroklorotiazida u terapiji. Relativni rizik za nastanak karcinoma dojke pri uporabi blokatora kalcijskih kanala, ali i drugih antihipertenziva nije bio povišen, vrijednosti su bile jednake onima u kontrolnim skupinama. Vjerojatnije je da je rizik od nastanka karcinoma bubrega vezan za samu patogenezu arterijske hipertenzije, a ne uz uporabu diuretske terapije. Zaključno, osim dokazane povezanosti uporabe hidroklorotiazida s nastankom nemelanomskog raka kože, valjanih dokaza za moguću karcinogenost drugih antihipertenziva još nema pa stoga preporučujemo u kliničkoj praksi nastaviti slijediti postojeće smjernice za liječenje arterijske hipertenzije uz reevaluaciju odluke o terapiji hidroklorotizadom u skladu s preporukama Hrvatskoga društva za hipertenziju., Numerous clinical trials have evaluated the potential cancerogenic effect of antihypertensive medications. Their influence on the development of prostate, skin, breast, kidney, and lung cancer has been examined. It was demonstrated that using antihypertensives does not elevate the total risk for cancer development. For some cancer groups there was even a reduction in risk of the development of malignant diseases under antihypertensive therapy. The results were the same in long-term use of the medications (>7.5 years), and longer application of the treatment did not lead to the expected increase in risk, with some studies finding a reduction in relative risk values with longer use of antihypertensives. No group of antihypertensives was associated with increased relative risk for the development of prostate cancer, and the use of beta-blockers and long-term use of alfa-blockers even had a protective effect. HALMED and the European Medicines Agency reported increased risk for the development of non-melanoma skin cancer with the use of hydrochlorothiazide. The Croatian Society of Hypertension recommends evaluating of the risk-benefit ratio of hydrochlorothiazide therapy in clinical practice, adequately informing the patient, and then deciding on the further use of hydrochlorothiazide in therapy together with the patient. The relative risk of breast cancer development was not increased due to the use of calcium channel blockers or other hypertensives, and the values did not differ from the control groups. It is more likely that the risk of kidney cancer development is associated with the pathogenesis of arterial hypertension rather than the use of diuretic therapy. In conclusion, apart from the demonstrated association between the use of hydrochlorothiazide and the development of non-melanoma skin cancer, there is still no valid evidence for the possible cancerogenic effect of other antihypertensives; in clinical practice we therefore recommend continuing to follow current guidelines for the treatment of arterial hypertension with a reevaluation of the use of hydrochlorothiazide therapy as recommended by the Croatian Society of Hypertension.
- Published
- 2019
121. Excessive daytime sleepiness as cardiovascular risk in Croatian obese patients
- Author
-
Mustač, Filip, primary, Matovinović, Martina, additional, Mutak, Tomislav, additional, Barun, Barbara, additional, Jug, Juraj, additional, Levicki, Rea, additional, Lovrić Benčić, Martina, additional, Jelaković, Ana, additional, and Jelaković, Bojan, additional
- Published
- 2019
- Full Text
- View/download PDF
122. Hypertension, obesity and STOP-Bang questionnaire in detecting obstructive sleep apnea
- Author
-
Mustač, Filip, primary, Matovinović, Martina, additional, Mutak, Tomislav, additional, Baretić, Maja, additional, Barun, Barbara, additional, Jug, Juraj, additional, Levicki, Rea, additional, Vinković, Ines, additional, Bradić, Lada, additional, Jelaković, Ana, additional, Lovrić Benčić, Martina, additional, and Jelaković, Bojan, additional
- Published
- 2019
- Full Text
- View/download PDF
123. OUTCOME IN ELDERLY PATIENTS WITH ANCA -- ASSOCIATED GLOMERULONEPHRITIS MANAGED WITH IMMUNOSUPPRESSIVE TREATMENT.
- Author
-
Kurtov, Karlo, Laganović, Mario, Karanović, Sandra, Dika, Živka, Ivandić, Ema, Živko, Marijana, Kos, Jelena, Fištrek, Margareta, Jelaković, Bojan, and Brinar, Ivana Vuković
- Published
- 2021
- Full Text
- View/download PDF
124. Hypoproteinemia as a prognostic risk factor for arteriovenous fistula failure
- Author
-
Premužić, Vedran, Hudolin, Tvrtko, Pasini, Josip, Zimak, Zoran, Hauptman, Dinko, Jelaković, Bojan, and Kaštelan, Željko
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,Arteriovenous fistula ,hemodialysis ,vascular access ,risk factors ,cardiovascular diseases - Abstract
INTRODUCTION: Any vascular access is of limited duration with many factors which influence survival in patients on chronic hemodialysis (HD). Hypoproteinemia as a marker of chronic illness is common among chronic HD patients. Our aim was to analyze the survival of the primary arteriovenous fistula (AVFs) and the risk factors which influence their patency and to test the hypothesis that patients with normal values of serum proteins have lower risk of AVF failure compared to patients with hypoproteinemia. METHODS: Seven hundred thirty- four consecutive patients were included who underwent creation of an AVF. The patients were prospectively followed-up for 2 years. Only patients with AVF function after a month from its creation were analyzed. The patients were divided into two subgroups, with normal and low serum protein levels (
- Published
- 2018
125. Debljina i hipertenzija
- Author
-
Baretić, Maja and Jelaković, Bojan
- Subjects
debljina ,hipertenzija ,gubitak tjelesne mase - Abstract
Debljina i hipertenzija povezane su bolesti. Mehanizmi hipertenzije koji prate debljinu uključuju retenciju natrija, aktivaciju simpatikusa i sustava renin-angiotenzin- aldosteron, inzulinsku rezistenciju, smanjenu aktivnost dušikova oksida i vaskularnu endotelnu disfunkciju. Arterijski tlak treba mjeriti u svih adipoznih bolesnika, ali i u svih bolesnika s hipertenzijom treba procijeniti prisutnost debljine. Mjerenje treba učiniti tlakomjerom s orukvicom koja odgovara nadlaktici adipozne osobe. Umjereni gubitak tjelesne mase u adipoznog bolesnika s hipertenzijom može znatno smanjiti arterijski tlak, a ima i povoljan učinak na metabolički profil. Iako će dugoročan gubitak tjelesne mase dovesti do sniženja arterijskoga tlaka, ne preporučuje se čekati da bolesnik oslabi kako bi se u budućnosti eventualno snizio arterijski tlak. Gubitak tjelesne mase u adipoznih osoba s hipertenzijom treba trajno poticati, a hipertenziju u adipoznih liječiti antihipertenzivima uz nefarmakološke intervencije usmjerene na smanjenje tjelesne mase.
- Published
- 2018
126. Citrinin in endemic nephropathy
- Author
-
Čulig, Borna, Ban, Božica, Peić, Ana, Momirović, Aleksandar, Jelaković, Bojan, Šostar, Zvonimir, Šikić, Sandra, and Krivohlavek, Adela
- Subjects
Balkan endemic nephropathy ,ELISA ,mycotoxins ,spot urine ,health care economics and organizations - Abstract
Balkan endemic nephropathy (BEN) is a tubulo- interstitial nephropathy associated with upper urinary tract cancers. Recently it was confirmed that aristolochic acid is a causative agent and BEN is considered an environmental form of aristolochic acid nephropathy. Citrinin (CTN) is a mycotoxin produced by several species of the genera Aspergillus, Monascus, and Penicillium and occurs mainly in stored grains. It was speculated that mycotoxins might play an additive role to aristolochic acid in etiophatogenesis of BEN. So far, that claim has not yet been proven. The aim of this study was to analyse urine CTN concentrations in residents of endemic villages. In this study we enrolled 38 patients who were diagnosed with BEN and another 38 subjects from non-endemic villages as the control. CTN was determined in spot urine by ELISA (enzyme-linked immunosorbent assay). For the statistical analysis of the data we used Student’s t-test. Our preliminary data show that CTN urine concentrations is higher in BEN than in non-BEN households, which might indicate poorer storage of harvested grain. This result should be confirmed on a larger number of subjects to determine the putative role of CTN in the etiophatogenesis of BEN.
- Published
- 2018
127. Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants
- Author
-
NCD Risk Factor Collaboration (NCD-RisC), Zhou, Bin, Bentham, James, Di Cesare, Mariachiara, Bixby, Honor, Danaei, Goodarz, Hajifathalian, Kaveh, Taddei, Cristina, Carrillo-Larco, Rodrigo M, Djalalinia, Shirin, Khatibzadeh, Shahab, Lugero, Charles, Peykari, Niloofar, Zhang, Wan Zhu, Bennett, James, Bilano, Ver, Stevens, Gretchen A, Cowan, Melanie J, Riley, Leanne M, Chen, Zhengming, Hambleton, Ian R, Jackson, Rod T, Kengne, Andre Pascal, Khang, Young-Ho, Laxmaiah, Avula, Liu, Jing, Malekzadeh, Reza, Neuhauser, Hannelore K, Sorić, Maroje, Starc, Gregor, Sundström, Johan, Woodward, Mark, Ezzati, Majid, Džakula, Aleksandar, Ivković, Vanja, Jelaković, Ana, Jelaković, Bojan, Jureša, Vesna, Majer, Marjeta, Mišigoj- Duraković, Marjeta, Musil, Vera, Pećin, Ivan, and Polašek, Ozren
- Subjects
blood pressure ,hypertension ,population health ,global health ,non-communicable disease ,sense organs - Abstract
Background Change in the prevalence of raised blood pressure could be due to both shifts in the entire distribution of blood pressure (representing the combined effects of public health interventions and secular trends) and changes in its high-blood-pressure tail (representing successful clinical interventions to control blood pressure in the hypertensive population). Our aim was to quantify the contributions of these two phenomena to the worldwide trends in the prevalence of raised blood pressure. Methods We pooled 1018 population-based studies with blood pressure measurements on 88.6 million participants from 1985 to 2016. We first calculated mean systolic blood pressure (SBP), mean diastolic blood pressure (DBP) and prevalence of raised blood pressure by sex and 10-year age group from 20– 29 years to 70–79 years in each study, taking into account complex survey design and survey sample weights, where relevant. We used a linear mixed effect model to quantify the association between (probit-transformed) prevalence of raised blood pressure and age- group- and sex-specific mean blood pressure. We calculated the contributions of change in mean SBP and DBP, and of change in the prevalence- mean association, to the change in prevalence of raised blood pressure. Results In 2005–16, at the same level of population mean SBP and DBP, men and women in South Asia and in Central Asia, the Middle East and North Africa would have the highest prevalence of raised blood pressure, and men and women in the high-income Asia Pacific and high-income Western regions would have the lowest. In most region- sex-age groups where the prevalence of raised blood pressure declined, one half or more of the decline was due to the decline in mean blood pressure. Where prevalence of raised blood pressure has increased, the change was entirely driven by increasing mean blood pressure, offset partly by the change in the prevalence- mean association. Conclusions Change in mean blood pressure is the main driver of the worldwide change in the prevalence of raised blood pressure, but change in the high-blood- pressure tail of the distribution has also contributed to the change in prevalence, especially in older age groups.
- Published
- 2018
128. Role of Plasmapheresis in the Management of Acute Kidney Injury in Patients With Multiple Myeloma: Should We Abandon It?
- Author
-
Premužić, Vedran, Batinić, Josip, Rončević, Pavle, Bašić-Jukić, Nikolina, Nemet, Damir, and Jelaković, Bojan
- Subjects
hemic and lymphatic diseases ,acute kidney injury ,bortezomib ,chemotherapy ,free light chains ,plasma exchange - Abstract
The aim of the current study was to determine whether plasmapheresis in combination with chemotherapy could significantly remove free light chains (FLC) in multiple myeloma (MM) patients with acute kidney injury (AKI) and therefore improve renal recovery and patient survival. During the study period, 29 patients with MM and AKI presented to our unit and were treated with two different therapy modalities (plasmapheresis with chemotherapy or bortezomib). At the end of treatment, a significant decrease of FLCs was present in the group treated with plasmapheresis compared to the bortezomib group. Patients treated with plasmapheresis had similar survival compared to patients treated with bortezomib. There was a significantly higher decrease of FLCs and longer survival in patients treated with three or more plasmapheresis sessions than in patients treated with two plasmapheresis sessions. Plasmapheresis therapy still remains a useful and effective method in the treatment of AKI in MM patients. Plasmapheresis significantly reduces FLCs compared to bortezomib especially with higher number of plasma exchange sessions but it must be combined with other chemotherapy agents in order to prolong renal recovery and therefore patient survival.
- Published
- 2018
129. Fibromuskularna displazija
- Author
-
Dika, Živka, Abramović, Ivana, Karanović, Sandra, and Jelaković, Bojan
- Subjects
I fibromuskularna displazija (FMD) ,renovaskularna hipertenzija (RVH) ,spontana disekcija koronarne arterije (SCAD) ,spontana disekcija cervikalne arterije (SCeAD) ,perkutana transluminalna angioplastika (PTA) - Abstract
Fibromuskularna displazija (FMD) rijetka je neaterosklerotična i neupalna vaskularna bolest koja može dovesti do stenoze, okluzije, aneurizme ili disekcije arterije. Uzrok FMD-a i njezina prevalencija u općoj populaciji nisu poznati. Najčešće se pojavljuje u mladih žena, iako se može pojaviti u bilo kojoj životnoj dobi. FMD je opisan u gotovo svim arterijama, ali najčešće zahvaća bubrežne i ekstrakranijalne arterije. Kliničke manifestacije FMD-a variraju i ovise o distribuciji zahvaćenih krvnih žila, tipu i težini vaskularne lezije (stenoza različitog stupnja, arterijska disekcija, arterijska aneurizma). U kliničkome tijeku FMD može progredirati tako da zahvaća nove krvne žile ili da na mjestu postojeće lezije dođe do suženja ili stvaranja aneurizmi pa i arteriovenskih fistula. Dijagnoza i klasifikacija FMDa ponajprije se temelji na slikovnim metodama. CT-angiografija (CTA), manje MR-angiografija (MRA), preporučuju se kao probirni i potvrdni test za FMD, dok je digitalna supstrakcijska angiografija (DSA) „zlatni standard“ za određivanje vrste i stupnja promjena i potvrdni test kod nejasnih slučajeva. Prema angiografskoj FMD-klasifikaciji razlikuju se dva tipa lezija: multifokalni („izgled biserne ogrlice“) i unifokalni. Liječenje bolesnika s FMD- om ovisi o naravi i lokalizaciji vaskularnih lezija, prisutnosti i težini simptoma, prethodnim vaskularnim događajima vezanim uz FMD, prisutnosti i veličini aneurizme i komorbiditetima. Liječenje može uključivati medikamentnu terapiju i praćenje ; endovaskularnu terapiju za stenozu (angioplastika bez proširnice, rijetko s proširnicom), disekciju (proširnicom) ili aneurizme (zavojnicama, proširnicom/ama) ; ili kirurško liječenje. U slučaju hemodinamički znatnoga renovaskularnoga FMD-a, metoda izbora je revaskularizacija perkutanom transluminalnom angioplastikom bubrežne arterije (PTRA) balonom. Nakon PTRA-e nužno je redovito pratiti bolesnike zbog rizika za restenozu.
- Published
- 2018
130. Epidemiologija arterijske hipertenzije i unos kuhinjske soli u Hrvatskoj (EH-UH 2)
- Author
-
Jelaković, Bojan, Bajer, Vesna, Banadinović, Maja, Bilajac, Lovorka, Capak, Krunoslav, Ćatić Ćuti, Edina, Džakula, Aleksandar, Gellineo, Lana, Ivančić, Ante, Jelaković, Ana, Knežević, Tamara, Krtalić, Branimir, Lazić, Goran, Leko, Ninoslav, Marinović Glavić, Mihaela, Miličić, Borna, Rakić, Davorka, Sarić, Marijana, Stupin, Ana, Stupin, Marko, Vasiljev Marchesi, Vanja, and Stevanović, Ranko
- Subjects
arterijski tlak, arterijska hipertenzija, kardiovaskularni rizik, prevencija, liječenje, kontrola - Abstract
Arterijska hipertenzija (AH) vodeći je uzrok pobola i smrti u svijetu, pa tako i u Hrvatskoj. Prema podacima EH-UH 1 istraživanja, koje je završeno prije 15 godina, prevalencija AH- a iznosila je 37%, uz vrlo lošu kontrolu liječenja - oko 20%. Jedan od glavnih razloga velike prevalencije i loše kontrole je prekomjeran unos kuhinjske soli koji prema rezultatima istraživanja u Hrvatskoj iznosi više od 11 grama dnevno. Podaci su bili temelj za izradu Strateškoga plana Vlade RH za smanjivanje unosa kuhinjske soli. Cilj projekta je: 1) na temelju podataka iz arhive prethodno provedenog istra živanja (EH-UH1) pozvati na kontrolni pregled sve ispitanike, pratiti klinički tijek bolesti i njen ishod ovisno o ulaznim pokazateljima ; 2) na način kako je rađeno i u EH- UH1, u EH-UH2 randomizirati novi uzorak opće populacije u Hrvatskoj, koristiti isti upitnik i način pregleda, mjerenja arterijskoga tlaka (AT) i određivanja pridruženih čimbenika rizika te odrediti prevalenciju, svjesnost, liječenje i kontrolu hipertoničara kao i dinamiku kretanja hipertenzije u Hrvatskoj tijekom 10 godina ; 3) u obje skupine ispitanika (post - EH- UH 1 i tijekom EH-UH 2) odrediti unos kuhinjske soli mjerenjem 24-satne na triurije ; 4) u istom uzorku urina odrediti količinu joda s ciljem utvrđivanja neškodljivosti smanjivanja unosa kuhinjske soli. Rezultati će omogućiti utvrđivanje najznačajnijih čimbenika za razvoj AH-a i njihove povezanosti s kliničkim ishodima.
- Published
- 2018
131. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension
- Author
-
Manolis, Athanasios J, Grossman, Ehud, Jelakovic, Bojan, Jacovides, Andrew, Bernhardi, David C, Cabrera, Walter J, Watanabe, Luis A, Barragan, Jaime, Matadamas, Norberto, Mendiola, Alfred, Woo, K.S, Zhu, Jun R, Mejia, Agnes D, Bunt, Ton, Dumortier, Thomas, and Smith, Ronald D
- Published
- 2000
- Full Text
- View/download PDF
132. Treatment of Hypertension Induced Albuminuria
- Author
-
Knežević, Tamara, primary, Gellineo, Lana, additional, Jelaković, Ana, additional, Premužić, Vedran, additional, Dika, Živka, additional, Laganović, Mario, additional, and Jelaković, Bojan, additional
- Published
- 2019
- Full Text
- View/download PDF
133. MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol
- Author
-
Parati, Gianfranco, primary, Agabiti-Rosei, Enrico, additional, Bakris, George L, additional, Bilo, Grzegorz, additional, Branzi, Giovanna, additional, Cecchi, Franco, additional, Chrostowska, Marzena, additional, De la Sierra, Alejandro, additional, Domenech, Monica, additional, Dorobantu, Maria, additional, Faria, Thays, additional, Huo, Yong, additional, Jelaković, Bojan, additional, Kahan, Thomas, additional, Konradi, Alexandra, additional, Laurent, Stéphane, additional, Li, Nanfang, additional, Madan, Kushal, additional, Mancia, Giuseppe, additional, McManus, Richard J, additional, Modesti, Pietro Amedeo, additional, Ochoa, Juan Eugenio, additional, Octavio, José Andrés, additional, Omboni, Stefano, additional, Palatini, Paolo, additional, Park, Jeong Bae, additional, Pellegrini, Dario, additional, Perl, Sabine, additional, Podoleanu, Cristian, additional, Pucci, Giacomo, additional, Redon, Josep, additional, Renna, Nicolas, additional, Rhee, Moo Yong, additional, Rodilla Sala, Enrique, additional, Sanchez, Ramiro, additional, Schmieder, Roland, additional, Soranna, Davide, additional, Stergiou, George, additional, Stojanovic, Milos, additional, Tsioufis, Konstantinos, additional, Valsecchi, Maria Grazia, additional, Veglio, Franco, additional, Waisman, Gabriel Dario, additional, Wang, Ji Guang, additional, Wijnmaalen, Paulina, additional, Zambon, Antonella, additional, Zanchetti, Alberto, additional, and Zhang, Yuqing, additional
- Published
- 2018
- Full Text
- View/download PDF
134. Arterial Stiffness in Balkan Endemic Nephropathy, an Environmental Form of Aristolochic Acid Nephropathy
- Author
-
Premužić, Vedran, primary, Ivković, Vanja, additional, Leko, Ninoslav, additional, Stipančić, Želimir, additional, Karanović, Sandra, additional, Jelaković, Ana, additional, Vuković Brinar, Ivana, additional, Dika, Živka, additional, and Jelaković, Bojan, additional
- Published
- 2018
- Full Text
- View/download PDF
135. Acute Kidney Failure as a Single Complication of Varicella Virus Infection in an Adult Patient
- Author
-
Premužić, Vedran, primary, Santini, Marija, additional, Laganović, Mario, additional, Ćorić, Marijana, additional, and Jelaković, Bojan, additional
- Published
- 2018
- Full Text
- View/download PDF
136. Increased arterial stiffness – similar findings in patients with inflammatory bowel disease without prior hypertension or diabetes and in patients with well-controlled hypertension
- Author
-
Prijić, Radovan, primary, Premužić, Vedran, additional, Brinar, Marko, additional, Krznarić, Željko, additional, Jelaković, Bojan, additional, and Čuković-Čavka, Silvija, additional
- Published
- 2018
- Full Text
- View/download PDF
137. MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: A randomised controlled trial protocol
- Author
-
Parati, G, Agabiti-Rosei, E, Bakris, G, Bilo, G, Branzi, G, Cecchi, F, Chrostowska, M, De la Sierra, A, Domenech, M, Dorobantu, M, Faria, T, Huo, Y, Jelaković, B, Kahan, T, Konradi, A, Laurent, S, Li, N, Madan, K, Mancia, G, Mcmanus, R, Modesti, P, Ochoa, J, Octavio, J, Omboni, S, Palatini, P, Park, J, Pellegrini, D, Perl, S, Podoleanu, C, Pucci, G, Redon, J, Renna, N, Rhee, M, Rodilla Sala, E, Sanchez, R, Schmieder, R, Soranna, D, Stergiou, G, Stojanovic, M, Tsioufis, K, Valsecchi, M, Veglio, F, Waisman, G, Wang, J, Wijnmaalen, P, Zambon, A, Zanchetti, A, Zhang, Y, Parati, Gianfranco, Agabiti-Rosei, Enrico, Bakris, George L, Bilo, Grzegorz, Branzi, Giovanna, Cecchi, Franco, Chrostowska, Marzena, De la Sierra, Alejandro, Domenech, Monica, Dorobantu, Maria, Faria, Thays, Huo, Yong, Jelaković, Bojan, Kahan, Thomas, Konradi, Alexandra, Laurent, Stéphane, Li, Nanfang, Madan, Kushal, Mancia, Giuseppe, McManus, Richard J, Modesti, Pietro Amedeo, Ochoa, Juan Eugenio, Octavio, José Andrés, Omboni, Stefano, Palatini, Paolo, Park, Jeong Bae, Pellegrini, Dario, Perl, Sabine, Podoleanu, Cristian, Pucci, Giacomo, Redon, Josep, Renna, Nicolas, Rhee, Moo Yong, Rodilla Sala, Enrique, Sanchez, Ramiro, Schmieder, Roland, Soranna, Davide, Stergiou, George, Stojanovic, Milos, Tsioufis, Konstantinos, Valsecchi, Maria Grazia, Veglio, Franco, Waisman, Gabriel Dario, Wang, Ji Guang, Wijnmaalen, Paulina, Zambon, Antonella, Zanchetti, Alberto, Zhang, Yuqing, Parati, G, Agabiti-Rosei, E, Bakris, G, Bilo, G, Branzi, G, Cecchi, F, Chrostowska, M, De la Sierra, A, Domenech, M, Dorobantu, M, Faria, T, Huo, Y, Jelaković, B, Kahan, T, Konradi, A, Laurent, S, Li, N, Madan, K, Mancia, G, Mcmanus, R, Modesti, P, Ochoa, J, Octavio, J, Omboni, S, Palatini, P, Park, J, Pellegrini, D, Perl, S, Podoleanu, C, Pucci, G, Redon, J, Renna, N, Rhee, M, Rodilla Sala, E, Sanchez, R, Schmieder, R, Soranna, D, Stergiou, G, Stojanovic, M, Tsioufis, K, Valsecchi, M, Veglio, F, Waisman, G, Wang, J, Wijnmaalen, P, Zambon, A, Zanchetti, A, Zhang, Y, Parati, Gianfranco, Agabiti-Rosei, Enrico, Bakris, George L, Bilo, Grzegorz, Branzi, Giovanna, Cecchi, Franco, Chrostowska, Marzena, De la Sierra, Alejandro, Domenech, Monica, Dorobantu, Maria, Faria, Thays, Huo, Yong, Jelaković, Bojan, Kahan, Thomas, Konradi, Alexandra, Laurent, Stéphane, Li, Nanfang, Madan, Kushal, Mancia, Giuseppe, McManus, Richard J, Modesti, Pietro Amedeo, Ochoa, Juan Eugenio, Octavio, José Andrés, Omboni, Stefano, Palatini, Paolo, Park, Jeong Bae, Pellegrini, Dario, Perl, Sabine, Podoleanu, Cristian, Pucci, Giacomo, Redon, Josep, Renna, Nicolas, Rhee, Moo Yong, Rodilla Sala, Enrique, Sanchez, Ramiro, Schmieder, Roland, Soranna, Davide, Stergiou, George, Stojanovic, Milos, Tsioufis, Konstantinos, Valsecchi, Maria Grazia, Veglio, Franco, Waisman, Gabriel Dario, Wang, Ji Guang, Wijnmaalen, Paulina, Zambon, Antonella, Zanchetti, Alberto, and Zhang, Yuqing
- Abstract
Introduction Masked uncontrolled hypertension (MUCH) carries an increased risk of cardiovascular (CV) complications and can be identified through combined use of office (O) and ambulatory (A) blood pressure (BP) monitoring (M) in treated patients. However, it is still debated whether the information carried by ABPM should be considered for MUCH management. Aim of the MASked-unconTrolled hypERtension management based on OBP or on ambulatory blood pressure measurement (MASTER) Study is to assess the impact on outcome of MUCH management based on OBPM or ABPM. Methods and analysis MASTER is a 4-year prospective, randomised, open-label, blinded-endpoint investigation. A total of 1240 treated hypertensive patients from about 40 secondary care clinical centres worldwide will be included -upon confirming presence of MUCH (repeated on treatment OBP <140/90 mm Hg, and at least one of the following: Daytime ABP ≥135/85 mm Hg; night-time ABP ≥120/70 mm Hg; 24 hour ABP ≥130/80 mm Hg), and will be randomised to a management strategy based on OBPM (group 1) or on ABPM (group 2). Patients in group 1 will have OBP measured at 0, 3, 6, 12, 18, 24, 30, 36, 42 and 48 months and taken as a guide for treatment; ABPM will be performed at randomisation and at 12, 24, 36 and 48 months but will not be used to take treatment decisions. Patients randomised to group 2 will have ABPM performed at randomisation and all scheduled visits as a guide to antihypertensive treatment. The effects of MUCH management strategy based on ABPM or on OBPM on CV and renal intermediate outcomes (changing left ventricular mass and microalbuminuria, coprimary outcomes) at 1 year and on CV events at 4 years and on changes in BP-related variables will be assessed. Ethics and dissemination MASTER study protocol has received approval by the ethical review board of Istituto Auxologico Italiano. The procedures set out in this protocol are in accordance with principles of Declaration of Helsinki and Good Clinical Practice
- Published
- 2018
138. Utjecaj urične kiseline na arterijski tlak i vaskularnu funkciju kod mladih odraslih muškaraca rođenih nakon intrauterinog zastoja u rastu
- Author
-
Laganović, Mario, Vrkić Kirhmajer, Majda, Vrkić Željković, Tajana, Brinar Vuković, Ivana, Karanović, Sandra, Dika, Živka, Premužić, Vedran, Rogić, Dunja, Banfić, Ljiljana, and Jelaković, Bojan
- Subjects
intrauterini zastoj rasta, arterijska hipertenzija, vaskularna funkcija, urična kiselina - Abstract
Uvod: Premda je poznato da osobe rođene nakon intrauterinog zastoja u rastu (IUGR) imaju veću incidenciju kardiovaskularnih bolesti kasnije u životu, mehanizmi koji to posreduju nisu do kraja poznati. Epidemiološki podaci pokazuju da povišena razina urične kiseline (UK) u serumu korelira s vaskularnom disfunkcijom i hipertenzijom.1-3 Cilj ovog rada je bio istražiti utječe li razina urične kiseline na arterijski tlak (AT) i vaskularnu funkciju u mladih muškaraca rođenih nakon IUGR. Pacijenti i metode: Uključeno je 95 zdravih muškaraca (21, 0 + 0, 89 godina) rođenih ispod 10. percentile porodne težine za gestacijsku dob (SGA) i 90 zdravih muškaraca (21, 5 + 1, 02 godina) s normalnim intrauterinim razvojem (AGA). Podaci o trudnoći i porodu dobiveni su iz registara poroda. Antropometrijski parametri, ambulantni i 24h arterijski tlak (AT), glukoza na tašte, profil lipida, eGFR, debljina intime-medije karotide (cIMT), brzina širenja pulsnog vala (PWV), centralni arterijski tlak (cAT) kao i indeks augmentacije (Aix) izmjereni su kod svih sudionika. Hiperuricemija je definirana vrijednostima UK > 360 µmol/L. Rezultati: SGA ispitanici su imali više vrijednosti UK u usporedbi s AGA grupom (406 vs. 307 p < 0, 001). SGA ispitanici s hiperuricemijom su imali viši indeks tjelesne mase (BMI), opseg struka (p < 0, 003), ambulantni sistolički AT (p = 0, 021), cAT (p = 0, 022), veću varijabilnost AT (p = 0, 021), nižu eGFR (p = 0, 021), kao i češće dislipidemiju (p < 0, 001) što nije bilo nađenoj kod kontrolne skupine. Nije bilo razlike u cIMT, Aix, PWV između skupina. Utvrđena je pozitivna korelacija između UK i BMI, OS kod obje skupine, te negativna korelacija s eGFR (p < 0, 001) u SGA skupini. Kod SGA ispitanika koji su prerano rođeni UK je pozitivno korelirala s varijabilnosti AT (p = 0, 003), cIMT (p = 0, 016) i negativno s porodnom težinom (p = 0, 009). U multiploj regresijskoj analizi BMI se pokazao kao ključna odrednica sistoličkog AT (ß = 0, 427 ; p < 0, 001). Zaključak: Naši rezultati potvrđuju grupiranje KV čimbenika rizika kod mladih odraslih muškaraca s povišenom razinom UK rođenih nakon IUGR. Nisu ustanovljene razlike u vaskularnoj funkciji prema vrijednostima UK. Međutim, kod osoba rođenih nakon IUGR primjećene su subkliničke promjene u karakteristikama AT, uglavnom u visini i povećanoj varijabilnosti sistoličkog AT, što još više dolazi do izražaja u prerano rođenih IUGR osoba. Navedeno može dijelom biti posljedica pojačane vazokonstrikcije kod IUGR ispitanika s povišenom razinom UK.
- Published
- 2017
- Full Text
- View/download PDF
139. PREHYPERTENSION AND SINGLE NUCLEOTIDE POLYMORPHISM RS13333226 OF THE UROMODULIN (UMOD) GENE
- Author
-
Domislović, Viktor, Đapić, Krešimir, Šimičević, Livija, Željković Vrkić, Tajana, Josipović, Josipa, Laganović, Mario, Fuček, Mirjana, Rogić, Dunja, Sertić, Jadranka, Jelaković, Ana, Dika, Živka, Kos, Jelena, Karanović, Sandra, Vuković Brinar, Ivana, Gellineo, Lana, Jelaković, Bojan, and Heagerty, Anthony M
- Subjects
prehypertension, single nucleotide polymorphism, polymorphism rs13333226 uromodulin (umod) gene - Abstract
doi: 10.1097/01.hjh.0000523999.98833.c4
- Published
- 2017
140. Endemska nefropatija – primjer kasnijeg vaskularnog starenja
- Author
-
Premužić, Vedran, Leko, Ninoslav, Stipančić, Želimir, Ivković, Vanja, Teskera, Tomislav, Karanović, Sandra, Vuković Brinar, Ivana, Dika, Živka, Laganović, Mario, and Jelaković, Bojan
- Subjects
krutost arterija, vaskularno starenje, endemska nefropatija - Abstract
Uvod: Bolesnici s terminalnim bubrežnim zatajenjem najčešće umiru od kardiovaskularnih (KV) incidenata, što je najčešće povezano s povišenom krutosti arterija (KA). Osim dobi, KA je snažno povezana u bolesnika s kroničnom bubrežnom bolesti (KBB) s regulacijom homeostaze kalcija i fosfata. Endemska nefropatija (EN) je kronična tubulointersticijska nefropatija karakterizirana kasnijim nastankom arterijske hipertenzije (AH) što utječe na vrijednost KA. Cilj rada je bio analizirati i usporediti ukupnu i KV smrtnost u EN bolesnika s drugim bolesnicima s terminalnim bubrežnim zatajenjem na hemodijalizi. Pacijenti i metode: Uključeno je ukupno 186 hemodijaliziranih bolesnika (90 muškaraca, 96 žena ; 67, 35 + 13, 07 godina) iz tri dijalizna centra u dva endemska područja. Učinjena su kontrolna mjerenja nakon 25 mjeseci na 97 preživjelih bolesnika (52 EN i 45 ne-EN) liječenih kroničnom hemodijalizom, 28 EN i 37 ne-EN bolesnika je umrlo (31 % vs. 39 % ; p = 0, 29) od različitih uzroka. Brahijalni arterijski tlak (AT) je bio mjeren pomoću Omron M6 uređaja, a markeri KA ; brzina pulsnog vala (PWV) i augmentacijski indeks (Aix) Arteriographom prije početka srednje dijalize u tjednu. Rezultati: Nismo pronašli razlika u spolu, pušenju, vrsti vaskularnog pristupa, dozi vezača fosfata, vitamina D, AH i brahijalnog AT između dvije skupine ispitanika. Nije bilo razlika u modalitetu dijalize osim nižim dozama ultrafiltracije u EN bolesnika (p < 0, 001) na početku i na kraju praćenja. EN bolesnici su bili značajno stariji (72, 0 ± 37, 1 vs. 62, 8 ± 15, 1 ; p < 0, 001) s kasnijim započimanjem dijalize na početku i na kraju praćenja. EN bolesnici su imali niže vrijednosti fosfata (1, 36 ± 0, 46 vs. 1, 6 1 ± 0, 42 ; p < 0, 001), umnoška Ca x P (3, 11 ± 1, 13 vs. 3, 76 ± 1, 19 ; p < 0, 001) te iPTH (10, 4 IQ 4, 5-19, 6 vs. 20, 2 IQ 12-50 ; p < 0, 001) i značajno niže vrijednosti PWV-a (9, 2 ± 1, 6 vs.10, 5 ± 1, 9 na početku ; 9, 3 ± 1, 3 vs.10, 5 ± 1, 9 kraj praćenja ; svi p < 0, 001). EN bolesnici su imali kraće trajanje AH prije započimanja hemodijalizom u odnosu na ne-EN bolesnike(36 (12-84) vs. 84 (60- 120) mjeseci ; p < 0, 001). Ne-EN bolesnici su umirali značajno češće od KV incidenata (32 % vs. 12 % ; p = 0, 001). Srednje vrijeme preživljenja je bilo značajno duže u EN skupini bolesnika (22, 3 (95 % CI 21, 2-23.5) vs. 18.2 (95% CI 16, 4-20.0) mjeseci ; p < 0.001). KV smrtnost je bila niža u EN skupini bolesnika (15, 0 % vs. 37, 8 %, HR 0.32 [0.18 - 0.59] ; log-rank p = 0, 0004). Zaključak: EN bolesnici unatoč tome što su značajno stariji su imali niže vrijednosti PWV-a. Endemska nefropatija je nezavisan prediktor niže KA koja se razvija sporije zbog nižih vrijednosti AT, blaže AH u preterminalnim stadijima bolesti, boljoj kontroli AH tijekom hemodijalize i boljoj regulaciji kalcija i fosfata što značajno pridonosi sporijoj progresiji bubrežne bolesti i nižoj KV smrtnosti u ovoj skupini bolesnika.
- Published
- 2017
141. BOLESNIK S HEPATITISOM C I MEMBRANSKOM NEFROPATIJOM
- Author
-
Željković-Vrkić, Tajana, Laganović, Mario, Dika, Živka, Kos, Jelena, Fištrek-Prlić, Margareta, Premužić, Vedran, Živko, Marijana, Karanović, Sandra, Vuković-Brinar, Ivana, Jelaković, Ana, Ivandić, Ema, Ivković, Vanja, Jelaković, Bojan, Knotek, Mladen, and Laganović, Mario
- Subjects
hepatitis C, membranska nefropatija - Abstract
Prikaza bolesnik s korničnim hepatitsom C i mišićnom distrofijom koji je razvio membransku nefropatiju
- Published
- 2017
142. Hrvatska aplikacija za poboljšanje kontrole arterijske hipertenzije
- Author
-
Đapić, Krešimir, Domislović, Viktor, Kovačić, Luka, Nekić, Ivica, Jelaković, Ana, Ivković, Vanja, Čavar, Ines, Bušić Bjelobaba, Lidija, Pajić, Vjeran, Ravić, Mario, and Jelaković, Bojan
- Subjects
arterijska hipertenzija, mobilna aplikacija, prototip - Abstract
Prevalencija arterijske hipertenzije u Hrvatskoj je visoka i iznosi 37, 5 % te je glavni čimbenik rizika za razvoj kardiovaskularnih bolesti.Napretkom tehnologije i globalizacijom sve veći udio stanovništva koristi pametne telefone što otvara nove mogućnosti poboljšanja kontrole kroničnih nezaraznih bolesti. Glavni cilj ovog projekta bio je razviti prototip mobilne aplikacije koja bi poboljšala kontrolu arterijske hipertenzije i educiranost korisnika o krvnom tlaku i povezanim komplikacijama.
- Published
- 2017
143. Continuous Veno-Venous Hemofiltration Improves Survival of Patients With Congestive Heart Failure and Cardiorenal Syndrome Compared to Slow Continuous Ultrafiltration
- Author
-
Premužić, Vedran, Bašić-Jukić, Nikolina, Jelaković, Bojan, and Kes, Petar
- Subjects
Cardiomyopathy ,Cardiorenal syndrome ,Continuous veno-venous hemofiltration ,Hemofiltration ,Ultrafiltration - Abstract
Continuous veno-venous hemofiltration (CVVH) could modulate the inflammatory response by removal of circulating cytokines and therefore improve cardiac function in patients with heart failure (HF). We hypothesized that patients with developed cardiorenal syndrome and treated with CVVH have lower risk for mortality than other patients treated with slow continuous ultrafiltration (SCUF). This was a prospective, longitudinal follow-up study for 24 months duration. In total, 120 patients were recruited from the intensive care units. Only patients with cardiorenal syndrome type 1 and 2 were enrolled. 54 CVVH and 23 SCUF patients survived. Mean survival time was longer in CVVH group with cardiomyopathy than in the SCUF group. When we compared patients with cardiomyopathy and hourly urine output
- Published
- 2017
144. BIOPSIJA BUBREGA POD KONTROLOM MSCT-A – METODA IZBORA U KOMPLICIRANIM SLUČAJEVIMA
- Author
-
Ivandić, Ema, Laganović. Mario, Novosel, Luka, Dika, Živka, Fodor, Ljiljana, Živko, Marijana, Željković-Vrkić, Tajana, Vuković-Brinar, Ivana, Fištrek-Prlić, Margareta, Jelaković, Ana, Jelaković, Bojan, Knotek, Mladen, and Laganović, Mario
- Subjects
MSCT vođena biopsija bubrega, biopsija bubrega - Abstract
Prikaz MSCT vođenih biopsija bubrega u jednom centru
- Published
- 2017
145. RIJETKE NASLJEDNE HEMATOLOŠKE BOLESTI U PACIJENTICE S POLICISTIČNOM BOLESTI BUBREGA – PRIKAZ SLUČAJA
- Author
-
Dika, Živka, Živko, Marijana, Željković Vrkić, Tajana, Knežević, Tamara, Gellineo Lana, Jelaković, Bojan, Knotek, Mladen, and Laganović, Mario
- Subjects
policistična bolest bubrega - Abstract
Opisan je slučaj pacijentice s autosomno dominatnom bolesti bubrega, nasljednom sferocitozom i trombofilijom.
- Published
- 2017
146. UČINKOVITOST EVEROLIMUSA U SMANJENJU BUBREŽNIH ANGIOMIOLIPOMA U BOLESNICE S TUBEROZNOM SKLEROZOM – PRIKAZ SLUĆAJA
- Author
-
Laganović, Mario, Željković-Vrkić, Tajana, Dika, Živka, Živko, Marijana, Karanović, Sandra, Fištrek-Prlić, Margareta, Kovačević-Vojtušek, Ivana, Jelaković, Bojan, Knotek, Mladen, and Laganović, Mario
- Subjects
tuberozna skleroza, everolimus - Abstract
prikaz pacijentica oboljele od tuberozne skleroze liječene everolimusom
- Published
- 2017
147. Uromodulin – Moguća uloga u aterosklerozi?
- Author
-
Šimičević, Livija, Đapić, Krešimir, Domislović, Viktor, Lovrić, Jasna, Božina, Tamara, Fuček, Mirjana, Josipović, Josipa, Jelaković, Ana, Dika, Živka, Gellineo, Lana, Jelaković, Bojan, and Reiner, Ž
- Subjects
uromodulin, predhipertenzija, ateroskleroza - Abstract
Uromodulin je pleiotropni glikoprotein s brojnim fiziološkim funkcijama. Do sada je poznata njegova regulacijska uloga u transportu soli, protektivna uloga mokraćnog sustava od infekcija kao i bubrežnih kamenaca, te bitna protektivna uloga u oštećenju bubrežne funkcije te i samog urođenog imuniteta. Najnoviji podaci predstavljaju niski serumski uromodulin kao nezavisni čimbenik rizika za kardiovaskularnu smrtnost. Osim navedenog, polimorfizam gena UMOD rs13333226, tj. varijantni alele G se povezuje s nižim vrijednostima arterijskog tlaka (AT). S obzirom na navedeno cilj navedenog rada bio je ispitati ulogu varijabilnosti gena UMOD u prehipertenziji (PHT), kao potencijalnog biljega tranzicije PHT u hipertenziju. Ispitivanje je obuhvatilo 496 ispitanika oba spola, 157 s AT < 120/80 mmHg) i 339 s AT ≥ 120/80 i 45 godina. Ustanovljena povezanost između varijantnog alela i nižih vrijednosti AT nije statistički značajna, što se može objasniti malim kontrolnim uzorkom. Nadalje, rezultati analize povezanosti genotipova UMOD s ostalim ispitivanim parametrima pokazali su povezanost varijantnog alela G alela s nižim vrijednostima ukupnog kolesterola, LDL- kolesterola i glukoze u obje dobne skupine. Detektirana je statistički značajna povezanost heterozigotnog genotipa A/G s visokim vrijednostima LDLkolesterola. Ovaj nalaz pozitivne heteroze otvara daljnja pitanja uloge kako i samog uromodulina tako i genotipa UMOD u metabolizmu lipida i u metabolizmu glukoze. UMOD predstavlja pleitropni gen koji ima svoju ulogu u razmatranju kardiorenalnog kontinuuma.
- Published
- 2017
148. Praktične smjernice za postavljanje dijagnoze arterijske hipertenzije Hrvatskog društva za arterijsku hipertenziju Hrvatskoga liječničkog zbora i Radne skupine za arterijsku hipertenziju Hrvatskoga kardiološkog društva
- Author
-
Jelaković, Bojan, Baretić, Maja, Čikeš, Maja, Dika, Živka, Fištrek Prlić, Margareta, Jelaković, Ana, Kos, Jelena, Kraljević, Ivana, Laganović, Mario, Likić, Robert, Lovrić Benčić, Martina, Pavlović, Draško, Počanić, Darko, Tiljak, Hrvoje, Vrkić Kirhmajer, Majda, Željković Vrkić, Tatjana, Reiner, Željko, and Miličić, Davor
- Subjects
Arterijska hipertenzija ,Smjernice ,Dijagnostika - Abstract
Arterijska je hipertenzija glavni neovisni čimbenik rizika za kardiovaskularni pobol i smrtnost. Prevalencija hipertenzije u većini zemalja pokazuje tendenciju rasta. Unatoč dostupnosti svih razreda antihipertenziva, kontrola liječenih hipertoničara nije zadovoljavajuća, za što postoji niz razloga i objašnjenja. Jedan od razloga jest i jaz između smjernica koje se temelje na činjenicama te mogućnostima njihova provođenja u stvarnome životu, što kao posljedicu ima lošu kontrolu hipertenzije i velik broj prijevremenih kardiovaskularnih događaja i smrti. Prvi korak u zbrinjavanju hipertoničara jest racionalna dijagnostika, što znači da pri tako masovnoj kroničnoj bolesti nepotrebnim pretragama ne povećavamo troškove, a s druge strane da pristupom na najmanju mjeru smanjimo propuste. Svrha je ovih smjernica za dijagnosticiranje arterijske hipertenzije da budu praktične i korisne u svakodnevnome radu. U njima je naglasak na konkretnim postupcima i podatcima s točno navedenim graničnim vrijednostima. Budući da je cilj smjernica ne samo usmjeriti i olakšati razmišljanja u svakodnevnome kliničkome radu nego i educirati, uz postupnike podsjećamo na neka temeljna znanja. U smjernicama ima nekoliko posve novih elemenata (upute o frekvenciji srca, mjesto i uloga mjerenja centralnoga arterijskoga tlaka i brzine pulsnoga vala, procjena bubrežne funkcije, zatim informatička tehnologija, tj. telemonitoriranje, primjena aplikacija za „pametne mobitele“). Na kraju smjernica uvršteno je nekoliko dodataka koji mogu biti korisni u svakodnevnome kliničkome radu, kao što su npr. upitnici za sindrom apneje u snu, upitnik o erektilnoj i seksualnoj disfunkciji, upitnik o kognitivnoj disfunkciji i drugi. U ovim smo smjernicama željeli biti praktični, precizni i realni s obzirom na mogućnosti koje nam pruža sredina u kojoj živimo. Svrha je bila na jednome mjestu obuhvatiti i prikazati što više konkretnih postupaka i podataka koji će biti korisni u radu, tako da liječnik ne mora gubiti vrijeme tražeći podatke bilo u samim smjernicama bilo u literaturi.
- Published
- 2017
- Full Text
- View/download PDF
149. UČINKOVITOST MIKOFENOLAT-MOFETILA U REZISTENTNIM PRIMARNIM GLOMERULARNIM BOLESTIMA
- Author
-
Ivandić, Ema, Laganović, Mario, Fištrek-Prlić, Margareta, Živko, Marijana, Željković-Vrkić, Tajana, Ćorić, Marijana, Karanović, Sandra, Jelaković, Ana, Vuković-Brinar, Ivana, Dika, Živka, Kovačević-Vojtušek, Ivana, Jelaković, Bojan, Knotek, Mladen, and Laganović, Mario
- Subjects
mikofenolat mofetil, rezistentne glomerulopatije - Abstract
Prikaz iskustva jednog centra u liječenju rezistentih glomerulopatija mikofenolat mofetilom koji se pokazao učinkovitim
- Published
- 2017
150. Aristolactam-DNA adducts anre a biomarket of environmental exposure to aristolochic acid out of established endemice nephropathy rural villages
- Author
-
Samardžić, Josip, Karanović, Sandra, Tomić, Karla, Karlović, Krešimir, Stipančić, Želimir, Brdar, Branko, Jakovina, Krunoslav, Hasukić, Sefik, Grollman, Arthur, and Jelaković, Bojan
- Subjects
endemic naphropathy ,aristolochic acid - Abstract
INTRODUCTION AND AIMS: Endemic nephropathy (EN) which was found in strict geographical areas in Balkan region is an environmental form of aristolochic acid nephropathy (AAN). Recently, we proved that the presence of aristolactam DNA adducts is the firm evidence for the exposure to aristolochic acid (AA), the confirmed etiological agent of EN i.e. AAN. Upper urothelial cancers (UUC) which occur in 50% of EN patients can be a solitary manifestation of exposure to AA. It has not been resolved why EN should be restricted only to several limited rural areas and it was questioned whether EN might unrecognized occur in villages out of established endemic focuses. Our aim was to confirm occurrence of this sporadic form of EN in villagers from Croatia and Bosnia analyzing the presence of aristolactam DNA adducts in kidney cortex of patients with UUC. METHODS: In this retrospective study (2005-2010), the samples of 72 UUC from 69 patients (27 men, 42 women) residing from Croatia and Bosnia were analyzed. The data on medical history, place of birth and residence as well as laboratory data were taken from hospital medical records. The histopathological data were reviewed by two pathologists. 46 patients had available specimens of renal cortex, and aristolactam (AL)-DNA adducts were quantified by (32)P- postlabeling and the adduct was confirmed by mass spectrometry. RESULTS: Out of 72 tumors, 37 and 35 cases were from EN and non-EN areas, respectively. Mean age of patients was 72 (41-84), no statistical difference was found between EN and non-EN patients (p=0.2398). Also no significant differences were found in tumor grade (EN (N): LG 9, HG 26 ; non-EN (N): LG 14, HG 18, v2=2.412 ; p=0.12) or tumor recurrence rate (EN vs. non-EN 16.2% vs.22.9%, v2=0.5064 ; p=0.47), as well as in patients’ kidney function (eGFR- MDRD) at the time of surgery (EN vs. non-EN 41.1 vs. 53.1 ml/min/1.73m2 ; p=0.2044). There were more women within the EN group (v2=3.9679 ; p=0.046) while hemoglobin values were higher in non-EN group (110 vs. 123 g/l ; p=0.0391). Positive AL-DNA adducts were found in renal cortex of 63% (29/ 46) patients with UUCs. As expected it was found in 18/28 patients from EN areas but importantly also in 11/18 patients from non- endemic villages. CONCLUSIONS: Based on the presence of aristolactam DNA adducts in 63% analyzed samples it can be concluded that aristolochic acid is the most frequent cause of UUC in this cohort of peasants from Croatia and Bosnia. Finding of aristolactam DNA adducts in patients residing out of established EN villages is the first molecular evidence for occurrence of EN i.e. AAN much broader than previously considered. This is an important alert for nephrologists, urologist and public health authorities which are taking care of villagers from all world regions where plants of Aristolochia genus are growing.
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.